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A BRIEF OUTLINE OF THIS THESIS 
The first commercial synthesis of acrylate plastics in 1927 by Röhm & Haas 
in Germany marked the beginning of the production of a new class of synthetic 
polymers. Nowadays acrylate based polymers are used in still growing quanti-
ties for an increasing number of applications. From the 1940's on a gra-
dual shift has taken place from a domination of large-scale production in 
closed systems of thermoplastic polymers, notably plexiglas, to a wide range 
of new ways of application resulting in a variety of risks of exposure, both 
in industrial and non-industrial settings. The new ways of exposure, together 
with the development and introduction of more precise toxicological test 
systems, set the need for further information on the toxicological profile 
of acrylic monomers. 
In this thesis a number of experimental studies are described which may 
contribute to the evaluation of risks, possibly associated with the use of 
acrylic monomers. Attention is primarily paid to dermatotoxicological aspects. 
On theoretical grounds a certain similarity between mutagenic chemicals and 
allergenic chemicals can be expected. An allergic contact dermatitis to a 
chemical can only arise after the chemical has reacted covalently with a 
carrier protein in the skin. A mutagenic effect proceeds from a reaction of 
the chemical with the genetic information-carrying part of the cell, viz. 
DNA. In view of the known allergenic properties of acrylic monomers, an 
investigation of their mutagenic properties seemed necessary. In addition, 
such a short-term mutagenicity test can be used as a predictive tool to 
assess the probability of carcinogenic effects of acrylic monomers on the 
skin. Moreover, the intended experimental use of acrylic monomers on the 
skin of human volunteers seemed to justify adding to the dermatotoxicological 
research a study on the mutagenic effects of these substances. 
After a short introduction on the principles of the chemical background 
of the synthesis of plastics, chapter 1 also deals with a number of 
applications of acrylic monomers. One of the most important applications 
is in the field of adhesives. The use of adhesives is, in general, asssociat-
ed with a relatively large risk of exposure, particularly of the skin. 
In oder to obtain some insight in the toxicological implications of the use 
of acrylics in adhesives, some basic principles of adhesive bonding are 
also described here. This is followed by a review of the toxicological 
literature on acrylic monomers. 
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Chapter 2 deals with the mutagenic properties of 27 monomeric acrylate 
esters and 5 acrylamides as tested in the Salmonella-microsome assay. The 
chapters 3-5 focus on dermatotoxicological aspects of certain aerylates, 
viz. allergenicity (ch. 3), permeation in vitro (ch. 4) and permeation in 
VÌVO (ch. 5). In the 6th chapter attempts to measure subclinical irritant 
effects on the human skin are described. 
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C H A P T E R 1 
INTRODUCTION 
1.1. PLASTIC MATERIALS 
1. 1. 1. Definition 
Plastics can be defined as synthetic macromolecular substances built up 
by repetition of small simple chemical units. 
1.2.3. Prinaiples of synthetic polymerization 
Plastic synthesis is based on repeated chemical binding between molecules, 
each with two or more reactive sites. In this way the starting molecules, 
the monomers, may react with each other to form a polymer. Monomers with 
two reactive groups form linear macromolecules while in polymerization 
reactions with participation of at least one chemical with more than two 
reactive groups networks are formed. In some cases it is possible to stop 
the polymerization process at a stage in which the reaction product con-
sists of only a few monomers having reacted with each other. Such an inter-
mediate product is called a synthetic resin or a prepolymer. At any desired 
moment the reaction may be restarted by heat, irradiation or the addition 
of catalysts or cross-linkers. This is done when the intermediate is used 
to produce the final product: application phase. Depending on the purpose 
which should be served by the endproduct several substances can be added 
during the polymerization reaction, e.g. fillers, plasticizers, U.V.-
sensitizers, U.V.-protectants, lubricants and pigments. 
Linear macromolecules are thermoplastic: when heated the intermoleeular 
van der Waals forces diminish and the shape of the material can be changed 
by external force. After cooling the material stays in a new shape. Network 
macromolecules are thermoset plastics. Their shape cannot be changed after 
heating. 
The polymerization reactions can be divided m two types (24): 
1. condensation reactions . , 
radical 
2. addition reactions: a. chain propagation 
.. ^ ionic 
b. step reaction 
ad 1. condensation reactions (flg. 1,2) 
Historically the oldest way to produce plastics, polycondensation is the 
polymerization of two or more starting materials reacting with each other 
in an equilibrium reaction, in which a macromolecular main product is formed 
together with one or more by-products. The latter products are low molecular 
substances, which may remain present as an impurity in the (pre)polymer. 
They are not chemically bound to the (pre)polymer. Catching away such by­
products promotes the reaction to proceed to the macromolecular endproduct. 
Examples of such by-products are water and formaldehyde. 
Interruption of condensation reactions in an early phase to produce pre-
polymers is possible. In the subsequent phase of producing the endproduct, 
such resins are combined with a variety of auxiliary substances, which have 
a modifying influence on the endproduct. In this way the endproduct can be 
made to meet the needs of the consumer: taylor-made endproducts. There are 
several ways to restart further polymerization of resins: 
- restoring the conditions which favour polymerization (and which had 
been altered in order to stop the reaction in the prepolymer phase). 
This, for instance, may be done by the addition of a catalyst, 
increasing the temperature or by changing the pH. 
- addition of cross-linkers. These are substances able to react with 
prepolymer molecules to produce the endproduct. If either the pre­
polymer or the cross-linker or both are threefunctional, network macro-
molecules are produced. 
Examples of substances made by polycondensation reactions are epoxy resins, 
polyamides, polyesters and phenolformaldehyde resins. 
figure 1 : Example of a polycondensation reaction, resulting in a linear 
macromolecule (thermoplastic polymer). 
О О 0 0 
Il li 'i » 
HO-C-R-C-OH + OH-R'-OH t ^C-R-C-0-R' -<Уъ + H O 
dicarboxylic dialcohol linear polyester 
acid 
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figure 2 : Example of a polycondensation reaction, resulting in a network 
plastic (thermoset polymer). 
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ad 2. addition reactions 
a. : radical chain propagation reactions (fig. 3) 
By tonnage, this is the most important way to produce plastics nowadays. 
The reaction is based on the activation of a double or triple bond in a 
monomer (predominantly C=C bonds, but C=0 and C=N are also possible) by 
free radicals. The first stage is called the initiation and this is consider­
ed to be the rate limiting step in this type of polymerization process. Free 
radicals are molecules or atoms with an unshared electron. They are formed 
when the addition of heat, irradiation, U.V.-light or a promotor results 
in the decomposition of radical donors like benzoyl peroxide and azodi-iso-
butyronitrile. 
A radical thus formed reacts with a monomer by addition, producing a 
monomer radical, which can react again with another monomer and so on. This 
is the propagation stage or growth stage. Interruption of this process is 
not possible. One does have the possibility to influence the chain length 
of the macromolecular endproduct by a number of factors such as the 
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figure 3: Radical chain propagation reaction of methyl methacrylate with 
benzoyl peroxide as a radical donor. 
© ¿ « ¿ © ^ ^ 2 <δ>;-ο· 
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poly(methy1 methacry1ate) 
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temperature and the presence of so called modifiers like carbon tetra­
chloride and mercaptans. 
This brings us to the third and final stage of the reaction: the terminat­
ion stage. We can distinguish two types of reactions in the termination 
stage: 1. reactions which terminate the growth of a single chain, but which 
have no influence on the reaction rate; 2. reactions which terminate the 
growth of a single chain and slow down the reaction rate. Examples of the 
first type are chain transfer with a modifier (fig. 4) or with a monomer 
(fig. 5). Reactions of the second type are: mutual combination of two 
growing radicals (fig. 6) and disproportionation between two growing radicals 
(fig. 7). 
figure 4: Chain transfer with a modifier, for instance a mercaptan. 
Я 
I 
,
Ч:Н--С*Н + RSH > "MTH^ -CH + RS* 
2
 ι
 2
 ι 
figure 5: Chain transfer with a monomer. 
H 
I 
M : H _ - C * + сн,=сн — » 'V'CH.-CH, + сн 0=с* 2
 I 2 I 2 I 2 2 I 
X X X X 
f igure 6: Mutual combination of 2 growing r a d i c a l s 
H H H H 
I l I I 
•VCH.-C* + *C-CH,^ » 'VCH.-C-C-CH-'V 
¿
 I | 2 2 I I ¿ 
X X X X 
figure 7: disproportionation between 2 growing radicals. 
H H 
I I 
мш-.-с* + *с-сн.л — » 'м:н=сн + H^C-CH.'V 2
 I I 2 I 2I 2 
X X X X 
Both propagation and termination reactions are essentially stochastic 
processes. Therefore the molecular weight of the endproduct is not uniform. 
To obtain Information on the degree of polymerization, two parameters are 
used. The first one is the number average molecular weight which indicates 
the number of molecules per unit weight, i.e. the mean molecular weight. 
7 
The second parameter is the weight average molecular weight which indicates 
the fraction of each molecular size by weight. The latter parameter is 
frequently used to describe the amount of residual monomer in the endproduct. 
A plastic, made using a single type of monomer is called a homopolymer. 
When two different monomers are the starting materials, the endproduct is 
called copolymer; m the case of three monomers terpolymer. Examples of 
plastics obtained by radical chain addition polymerization are poly(vinyl-
chlonde) , polystyrene, polyethylene, polypropylene, polyímethyl methacrylate) 
and ABS polymers (acrylomtrile, butadiene, styrene) . 
^2' ionic chain propagation reactions (fig. 8) 
This process is very similar to the radical chain propagation reaction 
involving initiation, propagation and termination stages. However, the 
growing molecule is an ion rather than a radical. The active center of chain 
growth may be a positively charged carbonium ion (cationic polymerization) 
or a negatively charged carbanion (anionic polymerization). The presence of 
catalysts and sometimes so-catalysts is necessary for the start of the react-
ion. Examples of polymers obtained by this type of reaction are: polycyano-
acrylates, polyformaldehyde and butyl rubber. 
figure 8: Anionic chain propagation reaction of a cyanoacrylate. 
weak base X-OH «—¡ OH + X 
CN I CN 
1
 , &+ *&-
Initiation C=C ÍZZ; C=C -
I I 
COOR COOR 
cyanoacrylate 
CN 
i -
 + 
HO-C-C + X 
I 
COOR 
Propagation 
CN CN CN CN 
l_ t I I -
HO-C-C + C=C » HO-C-C-C - С 
I I I I 
COOR COOR COOR COOR 
HO 
CN 
I 
C-C -
COOR 
CN 
l_ 
C-C 
I 
COOR 
Termination HO — 
CN 
I 
C-C 
I 
COOR 
CN 
I 
C-C~ 
H donor 
HO 
COOR 
CN 
I 
C-C 
I 
COOR 
CN 
I 
C-CH 
COOR 
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b: step addition reactions (fig. 9) 
This process, sometimes called rearrangement polymerization, is a stepwise 
reaction between two different monomers. A proton shift, i.e. a rearrange­
ment of a hydrogen atom is the essential part of the reaction. Like in all 
addition polymerization reactions, no by-products are formed. In the polymer 
the two monomers are present in an alternating sequence. The kinetics of 
the reaction are more akin to those in condensation polymerization and it 
is possible to stop the reaction halfway by underdosing one of the two 
starting monomers. In that case the resulting prepolymer is terminated on 
both ends with the monomer present in the excess. Upon adding the consumed 
monomer the reaction starts again. Examples are the polyurethanes. 
figure 9: Example of a step addition reaction. 
О О 
D V 
0=C=N-R-N=C=0 + HO-R'-OH » ^-NH-R-NH-C-O-R' -СП* 
diisocyanate dialcohol polyurethane 
1.2. APPLICATIONS OF ACRYLIC MONOMERS 
1.2.1. Introduction 
Many different polymers and resins are produced, using acrylic monomers. 
Polymerization occurs in a chain propagation reaction. The denominator of 
all acrylic monomers is the Н-,С=С^ „ structure, in which the double bond is 
2g
 a
NR 
polarized by an electron-withdrawing substituent at the α-carbon atom. 
In most cases this substituent is a carbonyl group (-C=0) but a nitnle 
group (-CSN) is also possible. 
The different classes of acrylic monomers and their main applications 
are described in this section. Because of their easy polymerization with 
each other and with other monomers like styrene and butadiene, a large 
number of copolymers exists. Only a few of them are mentioned below. 
1.2.2. Aorylia aaid, methasrylic aaid (fig. 10) 
Polymers of the sodium and ammonium salts of these acids have been used 
as emulsion thickening agents in latexes. Acrylic acid can be copolymerized 
with rubbers to produce carboxyl-containing elastomers. These are excellent 
adhäsives for more polar adherends like wood and metals. For the same reason 
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acrylic acid is added as a copolymenzing substance to certain (meth)acrylic 
ester compositions. 
0 
II 
figure 10: H-C=C-C-0H R = H : acrylic acid ¿
 I 
R R = CH,: methacrylic acid 
1.2.3. Acrylic esters 
1.2.3.1. mono(meth)aorylates (fig. 11) 
The homopolymer of methyl methacrylate is one of the plastics most 
frequently used. Display signs, lamp housings, wind screens and glazing 
material in aircraft applications are some examples in which the high light 
transmission and the good outdoorweathering properties of thermoplastic 
sheets of poly(methyl methacrylate) are used. 
Although - in view of the impossibility to interrupt a chain propagation 
reaction - one would only expect bulk production of such substances, this 
certainly does not hold true for acrylic esters. Along with the bulk product-
ion of materials as described above, there is also a craft-like production 
of tailor-made products, with more risks of exposure. Examples of the latter 
are the manufacturing of dentures, hearing aids, noise protectors and also 
the glueing of prostheses to bone in orthopaedic surgery. In these applicat-
ions a two-component system is used. The first component is a polymer powder, 
with a radical donor, for instance benzoylperoxide. The second component is 
the monomeric liquid methyl methacrylate containing an accelator (necessary 
to promote decomposition of the radical donor into radicals), for instance 
dimethyl parato luidme, and possibly additives such as antibiotics and of 
course an inhibitor. The two components are mixed together to form a doughy 
mass and this dough is applied for example to cement a prosthesis to the 
bone. Advantages of monomer-polymer systems are: 1. less shrinkage of the 
endproduct, resulting in lower strains, because the polymer powder does 
not shrink any further; 2. faster curing, since a part of the mixed substance 
has already polymerized. The newly formed polymer is attached to the polymer 
powder by means of the van der Waals intermolecular forces. 
0 
1 
figure 11: H9C=C-C-0-R' R = H : monoacrylate 
R R = CH,: monomethacrylate 
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Other polymers of mono(meth)acrylates, for instance poly(ethyl acrylate) 
and poly(methyl acrylate), are used as leather finishes, textile size and 
surface coatings. In pressure-sensitive adhesives, 2-ethylhexyl acrylate is 
frequently used, but a wide range of other acrylates is also used in this 
field. 
1.2.3.2. multifunctional acrylates (fig. 12, 13) 
Molecules with at least 2 reactive acryl groups belong to the class of 
the multifunctional acrylates. Di(meth)acrylate esters of dialcohols and 
tri- or tetra(meth)acrylate esters of polyalcohols are multifunctional 
acrylates generally used. They are applied in the production of photopolymer 
printing plates, U.V.-curable or electron beam curable inks and coatings, 
paints, glues and anaerobic sealants. 
They function by cross-linking other unsaturated, so called backbone 
molecules to each other, or by polymerization with themselves. The polymerizat­
ion reactions can be initiated by free radical formation, by radicals 
resulting from photoactivators, decomposing under the influence of U.V.-
light, by electron beam irradiation or "spontaneously". In the latter case 
the reaction starts when oxygen, which prevents autopolymenzation during 
storage, is excluded. Hence the name: anaerobic sealants. In addition, the 
reaction is accelerated by metal ions, coming off the surface of the 
substrate. 
О 0 
Il H 
figure 12: H.C^-C-O-R'-O-C-C^H. R = H : diacrylate 2 , | 2 
R R R = CH,: dimethacrylate 
О CH^-CH, О 
II I 2 3 II 
figure 13: H2C=CH-C-0-CH -C-CH2-0-C-CH=CH 
CH„-0-C-CH=CH„ 
2
 II 2 
0 
trunethylolpropane triacrylate 
1.2.3.3. acrylated resins (fig. 14) 
Acrylated resins are composed of prepolymers of a different chemical 
constitution, which have reacted with 2 or more acryl molecules which now 
form reactive sites. Important examples are acrylated epoxies , acrylated 
polyurethanes and acrylated polyesters. 
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Their main use is in the field of U.V. or electron beam curable inks and 
coatings. The simplest formulation of such inks and coatings consists of a 
photoinitiator (only for U.V.-curable products), a diluent system of multi­
functional acrylate esters and an unsaturated resin, for instance an 
acrylated resin. Methacrylated resins are also applicable in this field, 
although they require a slightly longer curing time. 
CH, 0 
I 3 II 
figure 14: H 0C=C - C-0-CH„-CH-CH_-
OH 
CH-, 0 
I 3 II 
H
n
C=C - C-0-CH.,-CH-CH -2
 - I 
OH 
a methacrylated epoxy resin 
1.2.4. hcrylonvtvvle (fig. 15) 
This monomer is widely used as a copolymer in manufacturing synthetic 
fibers. Approximately 20-25% of all synthetic fibers contain acrylonitnle 
as a copolymer. It is further used for rubbers and for the production of 
ABS terpolymers (acrylonitrile-butadiene-styrene) and styrene-acrylonitrile 
copolymers. These co- and terpolymers are low-cost thermoplastics used in 
e.g. the automobile industry and the production of suitcases and shoes. 
figure 15: H 2C=CH-CHN acrylonitnle 
1.2.5. Aarylamides (fig. 16, 17) 
Polyacrylamide is used as a flocculating agent, i.e. for the separation 
of solids, suspended in water. Furthermore it is used as a papermaking 
strengthener, as an emulsion thickening agent and as a grouting agent. A 
specific purpose is gel electrophoresis in biochemistry. Acrylamide as well 
as the structurally related substances are also used as copolymers in 
adhesives. Secondary acrylamides are used in the production of photopolymer 
printing plates. 
О 
U 
figure 16: H-C^H-C-NH. acrylamide 
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о 
II 
figure 17: H_C=CH-C-NH 
2
 I 
О CH. 
II I 2 
H2C=CH-C-NH 
Ν,N'-methylene-bis-acrylamide 1.2.6. Cyanoacrylates 
The excellent and rapid adhesion of cyanoacrylates to various adherends 
has given them the name of "super glues". The polymerization is an ion chain 
propagation reaction in which weak bases, generally water, function as ion 
donors. Within a few minutes the polymerization is completed. Cyanoacrylates 
are used as adhesives for plastics, rubber, glass, metals and m medicine 
for sealing wounds and as an alternative for surgical "suturing" of internal 
organs such as the liver and the spleen. In an alkaline environment poly-
cyanoacrylates can degrade by hydrolysis, in which case formaldehyde is formed 
as one of the degradation products (fig. 1Θ). 
figure 18- Degradation of polycyanoacrylate in an alkaline environment. 
CN CN 
I I 
-C-C-CH_-C-H OH 
I I 
COOR COOR 
CN 
1 
•C-C-CH-OH 
1 ¿ 
COOR 
+ 
CN 
"с-н 
1 
COOR 
CN 
.1 
C-H + 
I 
COOR 
н2о 
CN 
I 
HC-H 
I 
COOR 
OH 
CN 
I 
-C-C-CH,OH 
I 2 
COOR 
OH 
CN 
l_ 
-C-C + 
I 
COOR 
HC V н2о 
1.3. PRINCIPLES OF ADHESIVE BONDING 
An adhesive can be defined as a substance, capable of holding materials 
together by surface attachment. 
Skeist (141) describes adhesives as social substances."They unite 
materials, creating a whole that is greater than the sum of its parts" (141). 
To bring about this union adhesive and both adherends must be compatible. 
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Failure of the adhesive bond can be either at the interface between 
adhesive and adherend or in the adhesive itself. The strength within the 
adhesive is referred to as cohesion, while adhesion denotes the bonding 
power between adhesive and adherend. A good adhesion is achieved when the 
glue molecules are able to come into close contact with the substrate 
molecules. In order to achieve this they must first of all be able to move 
freely so that they can make their reactive sites orientate on corresponding 
sites in the molecules of the adherend (95) . Free movement of glue molecules 
is promoted by using a solution, a dispersion or a latex and also by heating. 
Close contact, the so-called wettability of the substrate, is possible when 
the surface tension of the glue is not higher than the critical surface 
tension of the adherend. 
A stable state will occur when the joining of glue and substrate has 
caused a decrease in free energy. This free energy change (AF) is described 
with the following formula: hF = ΔΗ - Τ.Δ5, where ΔΗ is the heat of mixing, 
Τ the temperature ("K) and ΔΞ the change in entropy. When 2 materials are 
combined the entropy change is in general positive, so there is a decrease 
in free energy when the heat of mixing is negative or not greater than Τ.Δ5. 
When hydrogen-bonding or any form of chemical bonding occurs, ΛΗ is negative, 
but for most weak- or non-polar pairs of materials ΔΗ is positive. It has 
been shown that when the solubility parameters of adhesive and adherend are 
approximately the same, the heat of mixing is lowest. Hence such combinations 
are the most stable ones. 
So we have 2 parameters which are useful in selecting an adhesive for a 
specific adherend, viz. the critical surface tension of adhesive and 
adherend, and the solubility parameters of both adhesive and adherend. 
The cohesive strength of the glue, which is in most instances smaller 
than the adhesive strength, is also developed by approach and orientation 
of sensitive spots in the glue molecules themselves. In addition chemical 
bondage may take place in certain adhesives namely by polymerization in situ 
or by cross-linking. Together with the transition from a fluid state to a 
viscous or solid state by cooling, also solvent removal and/or crystallizat­
ion, the result is a decrease of free energy and hence a stable state. 
One or more of the following mechanisms are active in adhesive bonding: 
1. mechanical bonding 
2. bonding at the atomic level: primary (= chemical) bonds 
3. bonding at the molecular level: secondary bonds 
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The secondary bonds are by far the most important in adhesives technology. 
There are 4 types of these intermolecular forces: 
1. dispersion forces 
2. dipole forces 
3. hydrogen forces 
4. induction forces 
Dispersion forces are important when large molecules are in close proximity 
to each other and they fall off rapidly as the sixth power of the distance 
between molecules. Flexibility of the molecules enables them to approach 
each other more closely, hence dispersion forces are greater in such 
molecules. For non-polar adhesives these forces account for virtually all 
the bonding power. 
Dipole forces are slightly less dependent on the proximity of the molecules. 
They are active in molecules bearing certain functional groups like an 
alcohol group -C-OH, carboxyl group HO-C=0# ketone group 0=C-, ester group 
RO-C=0 and an amine group -NH2. Never in such functional groups does the 
center of their negative loads coincide with the center of their positive 
loads. The resulting electrostatic force between the positive center of a 
functional group in one molecule and the negative center of a functional 
group in another molecule works as an attracting force. 
Hydrogen bonds are also important in the field of adhesives. They occur 
when a hydrogen atom of e.g. a carboxyl group 0=C-OH in the adhesive 
material is situated opposite a double bonded oxygen atom of a carboxyl 
group in the adherend material and vice versa. 
Induction forces arise when a electromagnetically loaded atom or molecule 
induces a non-permanent dipole in a neighbouring molecule. They are usually 
very small compared to the other forces. 
Of the primary bonds especially the covalent bonds are important in the 
adhesives technology. Chemical bonds are quite common in the adhesive itself 
but between adhesive and adherend they are less frequently encountered. 
Cellulose adherends (-0H groups) are partly bonded by covalent bonds when 
urea-formaldehyde (-NH groups) or phenol-formaldehyde (-OH groups) resins 
are used as adhesives. More recent examples are found in dentistry where 
zinc-polycarboxylate cement is used. The zinc atom is able to adhere to 
calcium phosphate-containing surfaces such as tooth enamel by weak chelate 
bonding. Another example is the addition of benzaldehyde glycol methacrylate 
to a modern dental composite resin (fig. 19) (96). This monomer can bind 2 
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benzaldehyde glycol methacrylate 
large prepolymers in the resin, but then an aldehyde group still remains in 
the new chain. This aldehyde group serves as an adhesion promoting agent for 
dentin. So here, too, we have a technically fast ideal situation in which 
adhesive and adherend are bonded both by chemical and secondary bonds. 
1.4. TOXIC EFFECTS OF ACRÏLATE ESTERS 
1.4.1. Early studies 
Reports on toxicological aspects of acrylate esters were published at 
first in the 1940's. At that time production of acrylates was mainly restrict-
ed to bulk-polymerization processes in industry. Therefore attention was 
focused on acute toxic effects of relatively high doses of monomers, as 
might occur during accidents in the production. 
Deichmann (37) investigated methyl, ethyl and 72-butyl methacrylate in 
rats, guinea pigs and rabbits and found oral LD^'s in the range of 10 g/kg 
bodyweight. A concentration of 3600 ppm methyl methacrylate in air proved 
lethal to rats, guinea pigs and rabbits with 5 hours of exposure (37). 
Application of methyl methacrylate in a dose of 38 g/kg bodyweight to the 
skin of rabbits did not result in any deaths (143) . The oral LD . of methyl 
acrylate in rabbits was 0.2 g/kg bodyweight, while a concentration of 237 
ppm in air caused death to rabbits and guinea pigs after an exposure of 7 
hours (152). Ethyl acrylate was studied by Pozzani et al. (127) and they 
found an oral LD
 n in rats of 1.0 g/kg bodyweight. Repeated exposures for 
7 hours to a concentration of 250 ppm ethyl acrylate in air caused death in 
rats. 
In short these studies indicated that a) the acrylate esters studied 
exhibit a higher acute toxicity than the methacrylate esters studied, and 
b) the longer the alkyl chain of the ester group, the lower the acute 
toxicity. 
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1.4.2. Tumorigenesis, teratogenesie 
Implantation of poly(methyl methacrylate) films subcutaneously in the 
abdominal region appeared to cause fibrosarcomas in mice (77) and in rats 
(78,119,120), although negative results in mice were published too (76). 
Painting the back of the neck of 10 rats with undiluted methyl methacrylate 
3 times a week for 4 months did not cause a single local tumor during their 
lifespan (120). Ethyl acrylate and methyl methacrylate were tested for 
carcinogenicity by oral feeding in rats and in dogs for 2 years. Doses for 
rats were 2000 ppm in drinking water, for dogs the maximum dose was 1000 ppm 
for ethyl acrylate and 1500 ppm for methyl methacrylate. No treatment-related 
tumors could be detected (17). 
Singh et al. (140) reported teratogenic effects of methyl, ethyl, n-butyl, 
isobutyl and isodecyl methacrylate in rats, after intra peritoneal administrat-
ion of doses ranging from 0.1 to 0.8 g/kg bodyweight. In another study (116) 
only some unspecific teratogenic effects were noted in rats, exposed to 
24,400 ppm methyl methacrylate in the air. The lack of teratogenic potential 
of inhaled ethyl acrylate (50 or 150 ppm in air, 6 hours a day) in rats was 
described by Murray et al. (110). The difference in routes of administration is 
a possible explanation for these conflicting results. A direct absorption 
from the peritoneum into the fetuses is postulated as an explanation of 
the observations of Singh et al. (65). The high doses, used in the 2 former 
studies (116,40) are likely to exert an unspecific teratogenic effect, due 
to the toxicity per se of the administered compound and not because of the 
teratogenic activity of the compound. 
Embryotoxic effects of methyl methacrylate and trimethylolpropane t n -
methacrylate were detected in three-day chicken embryos (75), while 1,3 
butyleneglycol dimethacrylate caused no significant level of malformations. 
Unlike the other chemicals tested m this study, methyl methacrylate caused 
no regular dose-response curve. A poor penetration into the embryo was 
postulated as a reason for the relatively low acute toxicity of methyl 
methacrylate for chicken embryos. Therefore it is difficult to classify 
methyl methacrylate among the other compounds tested with this assay. 
Conflicting results have also been reported regarding the mutagenicity of 
methyl methacrylate. In the S. typhimurium-microsome assay and in the cell 
transformation assay negative results were obtained (7). Poss et al. (126) 
detected methyl methacrylate as a mutagen using a forward bacterial mutation 
assay with S. typhimunum. They noted only a mutagenic effect at doses 
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which killed 80% or more of the bacteria. Under such extreme circumstances 
the assessment of mutagenicity becomes less reliable. 
So, apart from the occurrence of sarcomas after implantation of poly(methyl 
methacrylate) films - a phenomenon which is observed with virtually all 
plastics - the available evidence for carcinogenicity, teratogenicity or 
mutagenicity of acrylate esters is not overwhelming. At this place it may be 
noted that the older carcinogenicity reports do not meet today's require-
ments for a carcinogenicity study. A number of pitfalls in carcinogenicity 
studies (61) are enumerated m table 1. 
table 1 : Some pitfalls in carcinogenicity studies. 
- test compound not analysed: impurities 
- actual given dose not checked 
- too toxic a dose 
- dose level not constant 
- other compounds tested in the same room 
- insufficient number of animals at risk 
- insufficient number of control animals 
- no concurrent control animals 
- no dose-response curve 
1.4.3. Biotransformation 
Biotransformation of acrylate esters is believed to start along two lines 
(38) viz. hydrolysis and addition to sulfhydryl groups. Hydrolysis of methyl 
methacrylate to methacrylic acid and methanol appears to be the major path-
way (28,33). After oral or intravenous administration (5.7 mg/kg bodyweight) 
of methyl methacrylate to rats up to 88% was excreted as CO_ withm 10 days 
and up to 65% even within two hours (21), suggesting a very rapid biotrans-
formation. The excretion of methylmalonic acid in the urine made it likely 
that biotransformation of methyl methacrylate may proceed after hydrolysis 
by the valine pathway of catabolism to the citric acid cycle (21,34). 
The reactivity of acrylate esters to glutathione was shown in vitro 
(18,63) and in vivo (19). Acrylate esters are more reactive with glutathione 
and other free sulfhydryl groups than methacrylate esters (38). Silver and 
Murphy (139) reported a significant increase in toxicity of methyl and ethyl 
acrylate in rats after blocking the esterases by means of tnorthotolyl 
phosphate. The depletion of sulfhydryl groups was also significantly larger 
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in animals, pretreated with tnorthotolyl phosphate. The excretion of thio-
ethers, resulting from the reaction between acrylate esters and glutathione, 
in the urine after intra-pentoneal administration of methyl acrylate or 
methyl methacrylate, was shown in rats (38) and for methyl acrylate also in 
guinea pigs (137). 
1.4.4. Miscellaneous effects 
The effects of methyl methacrylate on drug-metabolizing enzymes in the 
liver have also been studied. Short term (2.7 to 13.5 minutes) high exposures 
(40,000 ppm m air) of mice extended the pentobarbital sleeping time (79), 
while long term (up to 160 hours) exposures of 100 or 400 ppm methyl meth-
acrylate in air shortened the pentobarbital sleeping time in raice (148). 
The former results may be interpreted as an acute depressive effect on enzyme 
activity, while the long term low level exposure is more likely to induce the 
synthesis of liver enzymes. A recent study (43) demonstrated transient 
decreases in activity of drug-metabolizing enzymes after intraperitoneal 
administration of 1.0 g/kg bodyweight methyl methacrylate for 3 consecutive 
days. 
Histological examination of rats exposed to 116 ppm methyl methacrylate 
in air revealed only slight and inconsistent evidence of liver changes (148). 
Such slight liver changes were also detected in mice exposed to 100 or 400 
ppm methyl methacrylate in air (148). McLaughlin et al. (104) found no his-
tological evidence of damage to lungs, liver or kidneys in mice after an 
exposure of 40 hours in 10 days to 1,500 ppm methyl methacrylate in air. 
After 6 months of exposure, 5 days a week, 7 hours a day, to 116 ppm methyl 
methacrylate in air (only slightly above the current Threshold Limit Value 
for humans of 100 ppm), histological examination of the exposed rats showed 
a focal haemorrhage in the tracheal mucosa and a reduced amount of cilia and 
microvilli on the tracheal cells (148). 
Inhalation of 400 ppm methyl methacrylate in air had little effect on the 
E.E.G. recordings of rats: only a depression of activity in the lateral 
hypothalamus and the ventral hypocampus was noted (71). Exposure of dogs to 
2000 ppm methyl methacrylate in air resulted in reduced gastro-intestinal 
motor neuron activity and in a transient decrease in the blood pressure 
(147). The fall in blood pressure after intravenous administration of methyl 
methacrylate is noted by several authors (37,68) and this may lead to serious 
consequences in humans during hip surgery, when the monomer-polymer mixture 
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is used to cement a prosthesis. 
A local neurotoxic effect of methyl methacrylate was described in humans 
after acquisition of a contact allergy to the same substance. The resulting 
paraesthesia heals only after months (50,57). Recently, Verkkala et al. 
(165) have investigated the local neurotoxicity of methyl methacrylate in 
rats. They exposed rat tail skin to undiluted methyl methacrylate under 
occlusion for 3 hours daily during 8 weeks. Daily absorption averaged to 
0.78 g/animal. After 4 weeks of exposure abnormal responses of the motor 
nerves were found and these effects were progressive until the end of the 
experiments. 
In a few reports the structure-activity relationship of (meth)acrylate 
esters was studied (80,146). The acute LDCQ in mice was selected as the 
parameter for toxicity. The best correlation was found with the octanol-
water coefficient, the hydrophilic acrylates appearing to be most toxic. 
The reactivity with glutathione appeared to have a lower predictive value. 
This finding may be an explanation for the fact, already noted by Autian (9), 
that the toxicological literature concentrates round the short-chained 
(meth)acrylates. Of course the extensive use of these monomers is another 
important factor. 
1.4.5. Dermatotoxicology 
Three aspects of dermatotoxicology of acrylate esters are discussed here: 
permeation, irritant capacity and sensitizing capacity. 
- permeation 
Both acrylate esters and methacrylate esters can be absorbed through the 
skin in sufficient quantities to cause the death of the animals tested. A 
standard dermal LD5Q in rabbits was reported to be 1.2 g/kg bodyweight for 
methyl acrylate and more than 9 g/kg bodyweight for methyl methacrylate (46). 
The ability of methyl methacrylate to penetrate through rubber gloves is well 
known (122), although only qualitative data at room temperature were given 
by these authors. 
- irritant capacity 
As a "by-product" of sensitization studies in guinea pigs, the irritant 
capacity of the compounds on shaven skin of that species is assessed. Depend-
ing on the sensitization method used, open or occluded applications on the 
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flank of the animal are used. In both methods of application van der Walle 
(158) found a decreasing irritant potential in his series from diacrylates-
monoacrylates-dimethacrylates to monomethacrylates. Bjòrkner (15) noted the 
strong irritant potential of the polyfunctional acrylates pentaerythritol 
triacrylate and trimethylolpropane triacrylate and a lower irritant potential 
of trimethylolpropane trimethacrylate. These effects were seen in patch 
testing both humans and guinea pigs. The application of diacrylates and other 
polyfunctional acrylates as cross-linkers for industrial purposes such as 
printing or painting, resulted in several cases of irritant contact der-
matitis in exposed workers. Beurey et al. (13) reported irritant effects up 
to bullous skin reactions in workers exposed to tetraethyleneglycol di-
acrylate. In subsequent human patch testing a 1% (v/v) concentration in 
acetone proved to be irritant. Ethanediol diacrylate and tnethyleneglycol 
diacrylate appeared to be at least as irritant in human patch testing. In 
another report (112) irritant reactions in workers exposed to pentaaerythn-
tol triacrylate, hexanediol diacrylate and trimethylolpropane triacrylate 
were described. Whether one or more of these acrylates was the cause for 
these skin reactions remained unclear. Emmett (44) observed 4 workers with 
an allergic contact dermatitis and one worker with an irritant contact 
dermatitis, due to contact with pentaerythritol triacrylate and trimethylol-
propane triacrylate. Butanediol diacrylate and hexanediol diacrylate were 
reported (92) to be the cause of an irritant contact dermatitis which 
developed 12-14 hours after ephemeral work contact. As is the case with all 
these occupational exposures described in these studies (13,44,92,112) no 
quantitative data regarding exposure were available. 
The delayed irritation observed by Malten et al. (92) was confirmed in 
an experiment with a volunteer, who was exposed to 87% hexanediol diacrylate 
in methyl ethyl ketone on the volar side of his forearms. The site exposed 
for 20 minutes became red after 15 hours, proceeding to bulla formation the 
next two days. The sites exposed for 5 and 10 minutes only showed redness 
(92). 
- allerg-io reactions 
There is extensive literature concerning allergic reactions to acrylate 
esters both in humans and in experimental animals. A summary is given in the 
thesis of Van der Walle (158). The comparisons between the publication of 
Bradford (20) of one patient sensitized to one substance, viz. methyl meth-
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acrylate, virtually the only acrylic in industrial use at that time, and 
the theses of Van der Walle (158) and B^örkner (15) is illustrative for 
the changes through which the acrylate technology has gone. However, the 
applicability of, for instance, the U.V.-curable acrylates is not as ex-
tensive as was previously expected. This is partly due to skin problems in 
exposed workers (113). Thus a reliable risk assessment of all available 
acrylics and methacrylics still seems of the utmost importance. 
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C H A P T E R 2 
NON-MUTAGENICITY OF 27 ALIPHATIC ACRYLATE ESTERS AND 
5 ACRYLAMIDES IN THE SALMONELLA-MICROSOME TEST 
2.1. INTRODUCTION 
Except for some viruses, DNA is the genetic material for all living 
organisms. This universal function of DNA is the scientific basis of virtually 
all short-term mutagenicity tests. A substance which causes damage to DNA in 
lower organisms like bacteria or yeasts, is believed also to be able to in-
duce damage to DNA in more complicated organisms. These changes in the DNA 
might have several effects, of which point mutations and chromosome breaks 
are the most important ones. A general term for all permanent changes m DNA 
is mutation. 
If a mutation occurs in a germ cell the result will be a change in the 
genome of the germ cell and hence possibly in that of a next generation. 
Since this mutation is an at random change in a finely tuned system the 
resultant effect is most likely to be deleterious. There are over 1000 known 
human diseases which are of genetic origin and several diseases with a high 
prevalence like diabetes and epilepsy are presumed to have a genetic component. 
If mutation occurs in a somatic cell there are no effects on future 
generations. Somatic mutation however may well be the first step in the 
process leading to cancer. Some authors (4,145) state that somatic mutations 
by environmental mutagens are the major cause for cancer, although this is 
disputed by others (27). There is evidence that mutations may be responsible 
for the activation of oncogenic viruses (131) . The fact that the majority of 
known carcinogens are also mutagens (102,132) supports the theory that a 
somatic mutation is a key event in the origin of cancer. So both the pre-
vention of genetic diseases in the future and the prevention of cancer in the 
existing generation seem to be partly dependent of the identification and 
subsequent elimination of mutagens from our environment. 
A substance is tested in a mutagenicity assay primarily to assess its 
capacity to produce damage to DNA. The extrapolation of these data into a 
categorization of the risk of mutagenicity to man is the next necessary step, 
which however is attended by substantial uncertainties. Although several 
attempts have been made to mimmalize these uncertainties, e.g. by the 
parallellogram model (142) no widely accepted method is known. The parallel 
23 
use of several mutagenicity assays, which measure different forms of genetic 
damage is necessary before trying to categorize the mutagenic risk of a 
chemical. 
Because of their high sensitivity, mutation tests in bactenae are 
particularly useful for the detection of mutagens. The salmonella-microsome 
test as developed by Ames and co-workers is the most widely used and also 
the most thoroughly validated bacterial mutation assay. Although there has 
been some dispute about it (3,8) it is now widely recognized that the test 
provides qualitative rather than quantitative information on the mutagenicity 
of a chemical (62). 
Esters and amides of acrylic acid and methacrylic acid are widely used in 
modern plastic technology. Over 500 million kg of methyl methacrylate alone 
is produced annually (70). The resulting acrylic resins and polymers are 
used for a variety of applications, such as prostheses, contact lenses, 
photopolymer printing plates, adhesivos and coatings. Workers m industry 
and craftsmen are exposed to various levels of acrylic monomers. Skin problems 
are frequently encountered in some trades (93). Exposure to acrylamide may 
lead to neurotoxic symptoms, notably a penferal neuropathy (42,144). 
The potentially harmful effects of plastic monomers became a major cause 
of concern to public health officers, especially since the discovery of 
vinylchloride as a mutagen (129) and a carcinogen to animals (166) and 
humans (32). Compounds which are structurally related to acryl esters and 
acrylamides like acrylonitnle and acrolein have been shown to be mutagenic 
(14,84,107,164). 
Glycidyl methacrylate was found to be mutagenic in the Ames test (154) and 
in a fluctuation test with Kl. pneumoniae (167). Methyl 2-cyanoacrylate was 
also detected as a mutagen in the Ames test (6) and Poss et al. (126) report-
ed the mutagenicity of methyl methacrylate in a forward mutation assay with 
S. typhlmunum. Acrylamide was reported to induce chromatid exchanges and 
breaks in spermatogonia of mice (138) . 
The reactivity of acrylate esters (18,19) and of acrylamide (63) with 
glutathione was clearly demonstrated. Delbressine (38) was able to establish 
experimentally that this reactivity was based on a Michael-type addition to 
the olefinic bond, i.e. a direct alkylating effect. Acrylamide was bound 
apparently irreversible to the red blood cells of rats in vivo (106). Singh 
et al. (140) reported teratogenic effects in rats after intraperitoneal 
administration of esters of methacrylic acid. A further review of teratolog-
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ical effects of the investigated substances is given in chapter 1. 
In view of the observed alkylating potency of these esters and acrylamides 
we became interested in the possible genotoxic effects of these substances. 
Therefore we decided to assess the mutagenic potential of 27 acrylate esters 
and 5 acrylamides with the Ames test (see Table 1). 
2.2. MATERIALS AND METHODS 
ehemicals 
Dimethyl sulphoxide (DMSO), 9-aminoacridine hydrochloride monohydrate, 
2-aminoanthracene, 4-nitro-o-phenylenediamine, benzo[α]pyrene and glycidyl 
methacrylate were purchased from Aldrich Europe (Belgium). Sodium azide and 
acrolein were obtained from Merck (F.R.G.). Nicotinamide adenine dinucleotide 
phosphate sodium salt (NADP), D-glucose-6-phosphate sodium salt and D-biotin 
were purchased from Sigma (U.S.A.). L-Histidme monohydrochlonde came from 
BDH (Great Britain). Bacto agar was obtained from Difco Lab. (U.S.A.) and 
nutrient broth No. 2 from Oxoid Ltd. (Great Britain). 
Names, manufacturers and purity of the tested compounds are shown in 
Table 1. The acrylate esters, synthesized In our own laboratory (Drs. E. 
Seutter) were prepared by treatment of acryloyl chloride or methacryloyl 
chloride with the required alcohol in the presence of tnethylamine and the 
acyl transfer catalyst 4-(dimethylamino) pyridine (64). N-t-butyl acryl-
amide was synthesized by the reaction of acrylomtrile with tertiary butanol 
and sulphuric acid in glacial acetic acid (124). The acrylamides were 
recrystallized from an appropriate solvent (methanol, 2-propanol or methylene 
chloride). Purity was checked on a Hewlett Packard 402 gas Chromatograph, 
equipped with a glas column of 1.8 m length, internal diameter 3 mm, con­
taining 3% OV.101 on Gaschrom Q 90-100 mesh, in connection with an Atomaire 
Flame Ionisation Detection. Conditions of use were: injection block 240°C, 
detector 300oC, column 70oC, isotherm 4 min increasing from 70 to 300oC at 
7.5<,C/min, helium carrier flow 30 ml/min. To prevent spontaneous polymerizat­
ion all esters contained hydroquinone or p-methoxyphenol in quantities rang­
ing from 1 mg/1 to 2.5 g/1. 
mutagenesis assay 
Basically, the procedure as described by Ames et al. (2) was followed, 
unless otherwise indicated. We used the S.typhimurium strains ТАІ535, ТАІ537 
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TABLE 1: Names, purity, structure and concentration range of compounds tested 
О 
1  
Mono (metti) acrylates: H-C=C-C-0-R 
R' 
Di(meth)acrylates : H.C 
О О 
Л " 
=C-C-0-R-0-C-i 
R' 
R'О 
II 
(Meth)acrylamides : H C=C-C-NHR 
C=CH„ 
I 2 
R' 
R' = H monoacrylate (1-7) 
R' = CH, monomethacrylate (8-15) 
R' = H diacrylate (16-21) 
R' = CH dimethacrylate (22-27) 
R' = H acrylamide (28-31) 
R' = CH methacrylamide (32) 
Compound Manufacturer Purity Tested concentration 
range (yg/plate) in 
Ames test 
1. Methyl acrylate 
2. Ethyl acrylate 
3. n-Butyl acrylate 
4. t-Butyl acrylate 
5. 7î-Pentyl acrylate 
6. Neopentyl acrylate 
7. n-Hexyl acrylate 
8. Methyl methacrylate 
9. Ethyl methacrylate 
Aldrich 
BDH 
Merck 
UCB 
>99% 
>99% 
>99% 
>99% 
own synthesis >99% 
own synthesis >99% 
Polyscience Inc. >99% 
Merck >99% 
Merck 98% 
-CH, 
-сн2-снз 
-(сн2)з-снз 
f3 
-с-сн, 
ι
 J 
с н
з 
-(сн2)4-сн3 
-CH--C-CH, 
¿
 I J 
с н
з 
-(сн2)5-снз 
-СНз 
-СН2-СНз 
40- 2500 
30- 2000 
30- 2000 
30- 2000 
25- 1600 
30- 2000 
25- 1600 
40-10000 
40- 2500 
TABLE 1 (continued) 
Compound Manufacturer Purity Tested concentration 
range (yg/plate) in 
Ames test 
10. re-Butyl methacrylate 
11. t-Butyl methacrylate 
12. ra-Pentyl methacrylate 
13. Neopentyl methacrylate 
14. n-Hexyl methacrylate 
15. 2-Hydroxyethyl methacrylate 
16. 1,2-Ethanediol diacrylate 
17. 1,4-Butanediol diacrylate 
18. 1,5-Pentanediol diacrylate 
19. Neopentanediol diacrylate 
20. 1,6-Hexanediol diacrylate 
21. Diethylene glycol diacrylate 
22. 1,2-Ethanediol dimethacrylate 
23. 1,4-Butanediol dimethacrylate 
24. 1,5-Pentanediol dimethacrylate 
Koch-Light >99% 
Polyscience Inc. >99% 
Polyscience Inc. >99% 
own synthesis >99% 
Polyscience Inc. 97% 
Merck >99% 
Polyscience Inc. 87% 
Merck 98% 
Polyscience Inc. 96% 
Polyscience Inc. 97% 
Polyscience Inc. 96% 
Polyscience Inc. 89% 
Merck 95% 
Polyscience Inc. 97% 
Polyscience Inc. 96% 
-(сн2)з-снз 
-C-CH-, 
I 3 
сн 3 
-(сн2)4-снз 
CH, 
-CH,,-C-CH, 
¿
 I л 
CH, 
-(сн2)5-снз 
-сн2-сн2-он 
- C H 2 K ; H 2 -
- C H 2 - ( C H 2 ) 2 - C H 2 -
-сн2-(сн2)3-сн2-
CH, 
I 3 
-CH0-C-CH0-2 , 2 
CH3 
-сн2-(сн2)4-сн2-
-сн2-сн2-о-сн2-сн2-
-сн2-сн2-
-сн2(сн2)2-сн2-
-сн2(сн2)з-сн2-
40-2500 
40-2500 
40-2500 
40-2500 
40-2500 
40-2500 
30-2000 
30-1000 
30-2000 
30-2000 
30-1000 
40-2500 
40-2500 
40-2500 
40-2500 
TABLE 1 (continued 2) 
Compound Manufacturer Purity Tested concentration 
range (vig/plate) in 
Ames test 
25. Neopentanediol dimethacrylate Polyscience Inc. 
26. 1,6-Hexanediol dimethacrylate Polyscience Inc. 
27. Diethylene glycol dimethacrylate Polyscience Inc. 
28. Acrylamide Aldrich 
29. N-hydroxymethyl acrylamide BDH 
30. N-tertiary butyl acrylamide own synthesis 
31. Ν,Ν'-methylene bis acrylamide Aldrich 
32. Methacrylamide Aldrich 
97% 
97% 
95% 
>99% 
98% 
98% 
98% 
98% 
^ 3 
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 -CH ,, -O-CH „ -CH
 n 
-сн2он 
сн 3 
-C-CH,, 
CH, о 
II 
-CH2-HN-C-CH=CH 
40-2500 
40-2500 
40-2500 
5-5000 
5-2500 
5-5000 
5-2500 
5-2500 
TA1538, TA98 and TAIOO, which were a gift of Dr. Ina Mattern (TNO, Ri^swi^k, 
The Netherlands). The strains were grown overnight in the nutrient broth 
in a shaking water bath at 370C until an optical density of 0.4 at 700 nm 
was reached. Dilution experiments indicated that this corresponded to 
0.5-1. 109 bacteria/ml. The trace amount of histidine (0.09 ymole/plate) was 
incorporated in the plates instead of in the top agar. The Aroclor-1254-
mduced rat liver S9 fractions were purchased from Litton Bionetics Inc. 
(U.S.A.). Phenobarbital-induced S9 fractions were prepared from male Wistar 
rats weighing approximately 200 g, who had received 0.1% (w/v) sodium phéno-
barbital in their drinking water during the 5 days preceding their sacrifice. 
Further preparation was performed according to Ames et at. (2). Protein 
content of the homogenate was 25-40 mg/ml, estimated by the method of Lowry 
et al. (83). S9 mix contained 0.1 ml homogenate per ml. 
All tests were performed on triplicate plates. Compounds were once tested 
with phénobarbital-induced S9 mix, once with Aroclor-1254-induced S9 mix and 
twice without any additional metabolizing system. Compounds were diluted 
in DMSO prior to use and the required amount was delivered in 0.1 ml DMSO 
to the top agar. At least 4 concentrations up to 2500 pg/plate or toxic 
levels were tested. To minimize loss of the volatile test substance, the 
petn dishes were transferred quickly after plating into air-tight glas 
jars. Solvent controls, positive controls and sterility controls for S9 mix 
were run with each experiment. The plates were counted manually after in-
cubation in the dark at 370C for 48-72 h. 
Methyl methacrylate, methyl, n-butyl, and hexyl acrylate were also tested 
in a modification of the liquid suspension test described by Rannug et al. 
(130). Bacteria (TAIOO only) were grown in nutrient broth as described above. 
Of the obtained suspension 0.9 ml was added to either 1.0 ml S9 mix (Aroclor-
mduced) or 1.0 ml 0.1 M phosphate buffer pH 7.4. To this mixture 0.1 ml of 
the test compound in DMSO was added. The tubes were tightly closed and placed 
in a shaking water bath at 370C for 90 min. Then 0.8 ml of this mixture was 
added to 3 ml molten top agar and poured in duplicate onto standard petn 
dishes, which were incubated and counted as described above. 
2.3. RESULTS 
The concentration range of the test substances is shown in Table 1 ; a step-
wise increase of 4 tunes the previous concentration was used, e.g. 40-160-
625-2500 yg/plate. When the background lawn of bacteria was sparse, the 
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TABLE 2: Control values observed during these studies. 
Strain 39" Spontaneous 
revertants 
(mean±S.D.) 
Positive controls 
(pg/plate) 
Revertants 
(mean±S.D.) 
TA1535 24± θ 
TAI 535 
TAI535 
TA1537 
TA1537 
TA1537 
ΤΑ153Θ 
TAI538 
ΤΑ153Θ 
ΤΑ9Θ 
TA98 
TA98 
TAI 00 
TAI 00 
TAI 00 
PB 
Aro 
-
PB 
Aro 
-
PB 
Aro 
-
PB 
Aro 
-
PB 
Aro 
15± 4 
13± 3 
9± 3 
8± 4 
11+ 5 
16± 4 
23+ 6 
30± 5 
32± 5 
43+ 6 
49± 5 
125±19 
120±15 
127±25 
Sodium azide (1) 
Glycidyl methacrylate (25) 
2-Aminoanthracene (0.7) 
9-Aminoacridine (70) 
2 -Ammoanthracene (0.7) 
4-Nitro-o-phenylenediamine (3) 
2-Aminoanthracene (0.7) 
Benzo[α]pyrene (5) 
4-Nitro-o-phenylenediamine (3) 
2-Aminoanthracene (0.7) 
Benzo[α]pyrene (5) 
Sodium azide (1) 
Glycidyl methacrylate (125) 
2-Aminoanthracene (0.7) 
Benzo[α]pyrene (5) 
481± 60 
137± 24 
192± 24 
340± 51 
224± 59 
596± 53 
1123±368 
130± 6 
779± 90 
1461± 47 
470± 30 
749± 61 
500± 25 
13261111 
8141 76 
PB, phenobarbital-induced S9 mix; Aro, Aroclor-1254-induced S9 mix. 
chemical was considered to be toxic in that concentration. In such a case 
also half that concentration was tested. All monoacrylates and diacrylates 
were toxic in the highest concentration tested, but none of the methacrylates 
or dimethacrylates. Acrylamide exerted a toxic effect in the highest con-
centration tested only in TA100. All other acrylamides tested, appeared to 
be non-toxic to the bacteria. None of the tested substances produced a 
significant increase of revertants,Î.e. a number of revertants which is more 
than 2-fold compared to the spontaneous, in any of the 5 Salmonella typhimu-
num strains. 
The use of glass plates instead of plastic plates had no influence on the 
results. Control values are shown in Table 2. Glycidyl methacrylate also 
contained p-methoxyphenol as an inhibitor. The addition of 2 yg hydroquinone 
to benzo[aJpyrene or 2-aminoanthracene had no influence on the response of 
TA100 to these mutagens. 
The results of the liquid suspension tests are presented in Table 3. Also 
with this method the acrylate esters failed to show a mutagenic response. 
No acrylamides were tested with the liquid suspension method, since their 
volatility is very low. 
2.4. DISCUSSION 
During the last few years a number of investigations have been published 
on the mutagenic activity of olefinic compounds. Several halogenated alkenes 
(10), allylic compounds (114), haloacroleins (133) and also acrylonitnle 
(107,164) were reported to be mutagenic. On the other hand, styrene (26,41,84) 
gave conflicting results regarding mutagenicity. Acrylamide was found non-
mutagenic to TA100 (109) but it appeared to produce chromosome damage in 
mice spermatogonia (138). Although generally substances which cause chromosome 
abnormalities also cause point mutations (60) there are some exceptions to 
this rule, of which benzene is the best known. Other mutagenicity tests with 
acrylamide need to be performed before a reliable classification of the 
genotoxic risk of acrylamide can be made. Of the other tested acrylamides 
no further data on their mutagenic potential were known to us. As for neuro-
toxicity, acrylamide itself appears to be more toxic than the other tested 
acrylamides (42). Methyl methacrylate was negative in a standard Ames assay 
and in a cell-transformation assay (7). However, Poss et al. (126) detected 
methyl methacrylate as a mutagen in a forward bacterial mutation assay, using 
Salmonella typhimunum TM677. They only observed a rise in the mutation 
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TABLE 3: Mutagenicity data in the liquid incubation modification of the Ames assay with strain TA100 
Compound Concentration 
(pg/2 ml in-
cubation volume) 
Number of revertants 
-S9 +S9 (Aroclor-induced) 
None 
Methyl acrylate 6000 
600 
60 
136±13 
100±10 
12B±10 
129114 
165+ 8 
113+ 9 
148± 7 
160±10 
Butyl acrylate 1500 
150 
15 
115± 7 
122±13 
131±12 
137±11 
144±12 
156± 8 
Hexyl acrylate 300 
30 
3 
100±12 
117±15 
121±15 
101±21 
142+11 
158± 6 
Methyl methacrylate 10000 
1000 
100 
121± 7 
130±11 
136± 6 
143+10 
145±14 
161111 
Acrolein 10 
15 
322±16 
378±35 
Mean±S.D. of 2 independent experiments of 2 selection plates each. 
frequency with additional rat liver homogenate at concentrations of methyl 
methacrylate which killed 80% or more of the bacteria. Under such extreme 
circumstances the assessment of mutagenicity becomes less reliable. Brusick 
(23) gives an example of a possible artefact with the mechanism of preferent-
ial selection. When the revertants are more resistant to the toxic effect 
of the test substance, a rise in the mutation frequency is observed, which, 
however, is not a mutagenic effect. 
It is a well-known fact that acrylate esters and other monomers can be 
bound rapidly to several plastics, but the use of glass plates instead of 
plastic plates had no influence on the results. Therefore we suppose that the 
binding of these chemicals to the plastic petri plate is not important under 
the conditions of the Ames assay. False negative results may occur because 
of the volatility of the compounds. Therefore we also used a liquid incubat-
ion test with the highly volatile acrolein as a positive control. In view 
of the control experiments performed, it seems unlikely that hydroquinone 
or p-methoxyphenol are able to suppress a mutagenic response under these 
circumstances. 
In addition to the possibility of a direct mutagenic effect due to the 
electrophilicity of these unsaturated esters (84) we could also think of an 
indirect mutagenic effect via the biotransformation to epoxides. Since 
several epoxy compounds are well-known mutagens and carcinogens (47,160,167, 
168) it is an important question whether such metabolites are formed during 
the metabolism of acrylic compounds. No such epoxy intermediates were 
detected in Vivo or in vitro both with phenyl-substituted acrylate esters 
(40) and with alkyl-substituted acrylate esters (38). These findings are in 
agreement with the observed lack of mutagenic potency of these esters. 
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C H A P T E R 3 
THE SENSITIZING POTENTIAL OF ACRYLIC CONSTITUENTS 
OF PRESSURE-SENSITIVE ADHESIVES 
3.1. INTRODUCTION 
Pressure-sensitive adhäsives are adhesives which are permanently in the 
tacky stage and they can be used without application of solvents or heat. 
They adhere to most ordinary surfaces when only slight pressure is applied. 
Their adhesion to most adherends is lower than their cohesion and the adhesion 
to the backing, so when a pressure-sensitive adhesive tape is removed from 
a surface, the glue molecules stick together on the tape, leaving only faint 
traces of glue on the adherend. Therefore the integrity of the adherend is 
almost completely preserved, which is a reason why this type of adhesives 
is very suited for use on the human skin. 
The application of adhesives on the human skin also means that in such a 
situation there is an occlusive contact of the chemicals in the adhesive 
layer with the skin. The occurrence of an irritant or an allergic reaction 
of the skin to a substance is stimulated by such an occlusive contact. 
Because of the generally short induction time of acute irritant contact 
dermatitis (94) most likely adhesives with acute irritant properties are 
detected before massive introduction of such an adhesive has taken place. 
It is much more difficult to recognize and rate chronic irritant properties 
of such pressure-sensitive adhesives which are involved when for instance 
stoma bags are affixed to an often already irritated skin around artificial 
orifices. Such rating should be possible with instrumental investigative 
procedures such as described in chapter 6. 
A third possible untoward effect of adhesive tapes is allergic contact 
dermatitis based on a very specific immunologic reaction which in practice 
only occurs after repeated contact with a given substance. It may take any-
thing between one week and a lifetime before an allergic contact sensitization 
has developed. A enumeration of factors which play an Important role in the 
induction of an allergic contact dermatitis is given in chapter 4.1. Once 
being sensitized, the only solution to prevent recurrence of the dermatitis 
is to avoid any further contact with the sensitizing substance, since in many 
cases even ephemeral contact is already sufficient to bring about a revival 
of the dermatitis. In addition, the use of other products containing chemically 
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related substances may also lead to recurrences of an allergic contact 
dermatitis (group-specific reaction). 
Consequently it is important to test the materials used in the production 
of pressure-sensitive adhesives, on their sensitizing potential, before they 
are introduced on the market. 
Because of their high clarity and good resistance to oxidation and UV-
radiation, acrylic monomers are often used to produce these adhesives, 
especially for applications on the human skin. The adhesive layer consists 
usually of a copolymer of 2-ethylhexyl acrylate (2-EHA) with polar monomers 
such as acrylic acid, acrylamide or N-alkyl maleamic acids (96) . These 
acrylic-based pressure-sensitive adhesives are often marketed with the re-
commendation "hypo-allergenic". There are some reasons to view this latter 
recommendation with suspicion. Firstly, in several so-called hypo-allergenic 
tapes the occurrence of allergenic derivatives of colophony was demonstrated 
(72, 136). These allergenic constituents of the adhesive tapes were able to 
cause a contact sensitization (136). Colophony is one of the top 20 common 
allergens (89). Secondly, the application of such adhesives to diseased skin 
is likely to be associated with a greater risk of contact sensitization. 
The easy sensitization of ulcerated or eczematous skin to topical medications 
is notorious (55) . Fisher (51) even noted a patient, who had developed an 
allergic contact dermatitis to parabens in a bandage, applied to diseased 
skin, while the same patient continued to use the parabens in other applica-
tions on other, healthy skin sites without any difficulty. 
At present it remains unclear which conditions need to be fulfilled, before 
the term "hypo-allergenic" can be used. A prerequisite before using this term 
should be at least the obligation to enumerate all ingredients on the label. 
To our knowledge 2 reports regarding human sensitizations after use of 
modern pressure-sensitive adhesives have been published (73, 66). In both 
publications a CuradR adhesive was incriminated as the causative factor. In 
the first report (73) , the 7 patients appeared to be sensitized to 2-ethyl-
hexyl acrylate and 3 of them also to N-t-butyl maleamic acid (table 6). In 
the other report (66) , N-dodecyl maleamic acid (table 6) was described as 
the sensitizing substance for the 2 patients. Human sensitizations to acryl-
amide and derivatives (table 5) are described in workers engaged in photo-
polymer printing processes (128, 91, 121), but until today not in people 
exposed to pressure-sensitive adhesives, containing acrylamides. 
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In order to obtain some insight in the sensitizing potential of the above 
mentioned possible constituents of pressure-sensitive adhesives, we decided 
to investigate 2-ethylhexyl acrylate, several acrylamides, alkyl maleamic 
acids and acrylic acid with guinea pig test methods, designed to evaluate 
contact sensitizing properties. A quantitative estimation of the sensitizing 
potential is also important for the occupational dermatologist, who wants to 
be able to advise industrial technicians on replacement of allergens by 
technically possible alternatives with a lower sensitizing potential. 
3.2. THE SENSITIZING POTENTIAL OF 2-ETHYLHEXÏL ACRYLATE IN THE GUINEA PIG 
3.2.1. Material and methods 
chemicals 
2-Ethylhexyl acrylate (2-EHA) was obtained from Ciago (The Netherlands), 
containing 120 mg/l hydroqumone as inhibitor. Purity was 94% (gas chromato-
graphically). Butyl acrylate and methyl methacrylate were from Merck (FRG). 
Hexyl acrylate and hexyl methacrylate were from Polyscience Inc. (USA), ethyl 
acrylate from BDH (England) and t-butyl acrylate from UCB (Belgium). Except 
for hexyl methacrylate, which was 97% pure, the remaining acrylates after 
distillation were over 99% pure (gas chromatographically). They contained 
either hydroqumone or p-methoxyphenol as inhibitor in quantities ranging 
from 30 to 160 mg/l. Freund's complete adjuvant was from Difco (USA). 
animals 
Female Dunkin Hartley outbred guinea pigs (Olac Ltd., England) were used 
for the study. They were housed in steel cages in pairs and fed on a pellet 
diet supplemented ad libitum with water. 
Freund's Complete Adjuvant Test 
A modification of Freund's Complete Adjuvant Test (159) was used, m which 
3, instead of 5 intradermal injections were given on days 0, 5 and 9, respect-
ively, in the shaved nuchal area of the guinea pig. The injected emulsion 
consisted of equal amounts of distilled water and Freund's complete adjuvant, 
in which the test substance was suspended to a final concentration of 0.5 M 
or 0.17 M (equal to about 9, and 3% respectively). Controls received the same 
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treatment without the test substance. The control group consisted of 10 ani­
mals,- the 2 experimental groups consisted of 16 guinea pigs each. 
Challenges were performed every 2 weeks from day 21 by open epicutaneous 
applications of 0.025 ml of the test substance in Aramek (1 part peanut oil, 
2 parts methyl ethyl ketone by volume) on a circular 2 cm2 area of the shaved 
flank of the animals. Reactions were read after 24 and 48 hrs. An animal was 
considered to be sensitized if it showed a clear confluent redness at 24 and 
48 hrs to a concentration of the test substance which did not give a visible 
reaction in control animals. 
In addition, we used in the first challenge 1 irritant concentration of 
2-EHA, viz. 3 M, while in all other challenges, only non-irritant concentrations 
were used. Hydroquinone was tested in the 3rd challenge at a concentration of 
1 M, using the same method as used for 2-EHA. 
cross reactions 
On day 63, after 3 consecutive challenges at day 21, 35 and 49, we determin­
ed the cross-sensitivity in 8 test animals, 4 from each group which had reacted 
m all 3 former challenges to 2-EHA (1 Μ ) , and in 6 control animals which up 
to that time had not reacted to 2-EHA (1 M) in any challenge. The challenge 
procedure was the same as described above. To verify the reactivity of the 
animals to 2-EHA, they were tested on days 77 and 105 with a 1 M and a 0.3 M 
solution of 2-EHA. The control animals were only tested on day 105. 
adhesive tapes 
Testing of the adhesive tapes was carried out in several ways on days 77, 
91 and 105 with the same animals as used in the cross reaction challenge. 
(a) We applied a tape directly to the guinea pig skin, removed it after 48 hrs 
and read the reactions after 50 and 72 hrs. 
(b) We applied 0.025 ml of 1 of 4 solvents (ethanol, olive oil, methyl ethyl 
ketone, distilled water) to the Whatman paper of a Silverpatch (89) and 
covered each of them with one of the tapes to be investigated. The wetted 
Silverpatches plus tape were then fastened to the guinea pig skin with an 
elastic bandage (Coban, 3 M Co., USA) encircling the trunk. After 48 hrs 
this dressing was removed and reactions were read after 50 and 72 hrs. In 
this way a situation similar to human patch-testing was created. 
(c) We immersed 100 cm2 of a tape in 3 ml of ethanol or Aramek in a closed 
beaker for 24 hrs and used this solution for an open elicitation test 
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as described above. 
Methods (a) and (b) were used for the tape brands Scanpor (Norgesplaster, 
Norway) and Leukopor (Beiersdorf, FRG). Method (c) was used for these 2 
brands and for Band-aid (Johnson & Johnson, USA), Curafix (Lohmann, FRG) and 
Sparaplast (Lab. de pansement et d'hygiène, France). 
3.2.2. Results 
With both induction concentrations (0.17 M and 0.5 Μ), sensitization of 
guinea pigs to 2-EHA was readily demonstrated. The lower induction concentration 
gave a slightly higher response (Table 1). In the second challenge on day 35, 
3 out of 10 control animals also appeared to be sensitized. Cosensitizations 
to the inhibitor hydroquinone occurred in 4 experimental animals, 3 from the 
group induced with 0.5 M 2-EHA and 1 from the group induced with 0.17 M 2-EHA. 
TABLE 1: Sensitizing potential of 2-EHA in the modified Freund's Complete 
Adjuvant Test. 
Induction 
concentration 
0.5 M 
0.17 M 
controls 
No. of 
animals 
16 
16 
10 
Challenge 
concentration* 
1 M 
ι M 
1 Μ 
Number 
day 21 
6 
13 
0 
of sensitized 
day 35 
11 
13 
3 
animals 
day 49 
9 
11 
1 
*In Aramek (1 part peanut oil, 2 parts methyl ethyl ketone v/v). 
TABLE 2: Cross reactions to other acrylate monomers of animals sensitized 
to 2-EHA. 
Monomer Concentration* No. of positively reacting Control 
animals out of the total animals 
number of tested animals 
ethyl acrylate 
«-butyl acrylate 
t-butyl acrylate 
hexyl acrylate 
methyl methacrylate 
hexyl methacrylate 
3 M 
3 M 
undiluted 
1 M 
undiluted 
3 M 
3/8 
7/8 
0/8 
2/8 
0/8 
0/8 
0/6 
0/6 
0/6 
0/6 
0/6 
0/6 
*In Aramek (1 part peanut oil, 2 parts methyl ethyl ketone v/v) 
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No control animals appeared to be sensitized to the inhibitor. Cross sensitiza­
tions are shovm in Table 2. With the exception of t-butyl acrylate, all tested 
monoacrylates (ethyl, η-butyl, hexyl acrylate) gave at least some positive 
reactions. Reactions to the 2 methacrylates (methyl and hexyl) were not 
observed. 
On day 77, all test animals reacted to 2-EHA in both concentrations. On 
day 105, 5 out of 7 animals (1 died) reacted to the 1 M concentration of 2-EHA, 
while none of the 6 control animals reacted. 
All tests with the adhesive tapes gave negative results. The immersion 
extracts of Band-aid with ethanol as well as with Aramek proved to be mildly 
irritant to the guinea pig skin. 
3.2.3. Discussion 
The strong sensitizing potential of 2-EHA in guinea pigs is in accordance 
with the findings of Van der Walle et al. (156), who showed that monoacrylates 
were potent sensitizers in Freund's Complete Adjuvant Test. The higher 
sensitization incidence obtained with the lower induction concentration is 
in contrast to the findings of Magnussen & Kligman (85), who observed an 
increasing sensitization incidence with increasing induction dose. This was 
also reported in human test methods (99). A possible explanation of the effect 
observed by us may be that with the higher dose, a significant amount will not 
be bound in the skin, but will reach the central part of the lymphatic system 
unchanged, possibly entailing the production of suppressor lymphocytes (11). 
The strong sensitizing potential of 2-EHA is also demonstrated by the fact 
that 3 out of 10 control animals showed allergic responses 2 weeks after a 
single application of the challenge test concentrations on day 21. 
As shown by Van der Walle (155) , concomitant sensitization to hydroqumone 
interfered with neither the sensitizing potential of the acrylate under 
investigation nor the cross reaction pattern. 
The observed cross reactions with other monoacrylates together with the 
non-reactivity of the monomethacrylates, correlate well both with the findings 
of Van der Walle & Bensink (157) on guinea pigs and with the observation of 
Jordan (73) in 5 human beings, of a broad cross reaction pattern with mono­
acrylates, but only with one methacrylate, viz. hydroxypropyl methacrylate. 
This methacrylate was unfortunately not available to us. The non-reactivity 
of our guinea pigs to t-butyl acrylate might be due to the high volatility 
of this monomer, which was applied undiluted and not occluded. With guinea 
40 
pig test methods, monoacrylates are more potent sensitizers than monometh-
acrylates (156). This is reflected in the number of reported sensitizations 
in humans(134). A theoretical base for the observed differences in sensitizing 
potential of monoacrylates vis-à-vis monomethacrylates, can be postulated. 
Generally, a covalent binding in the skin to a carrier protein is necessary 
to induce contact sensitization (125, 153). Acrylate esters can react easily 
in a Michael-fashion with nucleophiles like -SH or -NH- groups in proteins, 
due to the electron-withdrawing effect of the functional ester group (39). 
The presence of a methyl group at the α-carbon may diminish this electron-
withdrawing effect with a consequent fall in reactivity towards nucleophiles. 
The lower sensitizing potential of methacrylates is compatible with this theory. 
H2Ç=CH-C=0 < > н2с*-сн=с-о| 
O-R / O-R 
site of nucleophilic attack 
The negative results of testing with the adhesive tapes were not totally 
unexpected, as previous testing had indicated that the sensitized animals 
reacted to 2-EHA only in concentrations of 0.3 M or higher. We only knew 
that Scanpor tape contained 2-EHA, which is why we tested this brand in the 
most elaborate way. Obviously, the concentration of free penetrable 2-EHA 
in the tape was so low that no reactions could be observed. This seems to be 
in contrast with Jordan's observation (73) of 7 patients sensitized to 2-EHA 
present in an adhesive tape. Technical improvements m the manufacturing of 
pressure-sensitive adhesive tapes may also be responsible for the observed 
lack of reactivity of the tapes in the guinea pigs. Several years ago, the 
adhesives were made by the polymer solution method, in which case solvent 
impurities, low molecular fragments and small quantities of monomers could 
be found in the end product. Nowadays, solution polymerization has been 
replaced by emulsion polymerization. The use of this latter method gives a 
more complete polymerization, resulting in a lower concentration of reactive 
low molecular substances in the end product (96). Furthermore, this method 
results in an environmental improvement, as only water and a detergent are 
needed m the production of aqueous acrylic dispersions, without any toxic, 
highly inflammable solvents. 
The observed irritant reaction to the extract of 1 of the tapes is presumably 
due to the presence of such a detergent. For minimalizmg allergological risks 
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the emulsion polymerization method appears to be substantially better than 
the solution polymerization method. In the classic adhesives colophonium 
(30) turpentine peroxides (31) and rubber chemicals (29) are recognized as 
rather frequent sensitizers. Compared to them, adhesives made by emulsion 
polymerization seem to have a low allergenic potential. Although introduced 
about 5 years ago very few "plaster irritation" patients have been encountered 
so far. A disadvantage of the modern adhesives is, generally, their lower 
adhesive strenght, compared to the classic adhesives. 
3.3. SENSITIZING POTENTIAL OF ACRYLAMIDES AND ALKYL MALEAMIC ACIDS TN THE 
GUINEA PIG 
3.3.1. Materials and methods 
ohem-iaals 
Acrylamide, methacrylamide and Ν,Ν'-methylene bis acrylamide were from 
Aldnch (Belgnum) . N-hydroxymethyl acrylamide came from BDH (U.K.), while 
maleamic acid was obtained from Koch-Light (U.K.). N-t-butyl acrylamide, 
N-t-butyl maleamic acid and N-dodecyl maleamic acid were synthesized in the 
department of organic chemistry of the section of occupational dermatology 
(drs. E. Seutter). All substances were recrystallized from an appropriate 
solvent in order to obtain a purity, better than 98% (gas chromatographically). 
animals 
Female Hartley outbred guinea pigs (Broekman Institute, The Netherlands) 
weighing approximately 400 g at the beginning of the experiments were used. 
They were housed in pairs in plastic cages in airconditioned rooms of our 
animal laboratory and fed on a pellet diet supplemented ad libitum with water. 
sensitization procedures 
The modified Freund's Complete Adjuvant Test was used as described in 
chapter 3.2. In the injected emulsion the final concentration of test substance 
was 0.5 M, which equals to 3.5% for acrylamide, 4.2% for methacrylamide and 
5.0% for N-hydroxymethyl acrylamide. Only these 3 substances were investigated 
with the Freund's Complete Adjuvant Test. Challenges were performed on day 21 
and day 35 as described in chapter 3.2. Only non-irritant concentrations were 
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used. On day 49 the sensitized animals were tested for cross-reactivity to 
related substances by open epicutaneous application of 0.1 ml of the substance 
in petrolatum, in the same concentration as used in the challenges in the 
Split Adjuvant Test. Maleamic acid was tested in a 2.5 M concentration. The 
Split Adjuvant Test as described by Maguire (86) was used by us with some 
minor modifications. Chronologically the procedure was as follows: 
Day 0 : 1. To reduce damage to the skin by scratching, adhesive tape (Leuko-
por, Beiersdorf, FRG) is wrapped around the rear feet of the 
guinea pigs. They remain in place during the whole study and are 
replaced if lost. 
2. The nuchal area of the guinea pig is clipped. 
3. An elastic bandage, 3.8 cm width (Coban, 3 M, USA) is wound around 
the shoulder area of the animal. By means of scissors a window of 
2x2 cm is made in this dressing in the nuchal area. The bandage is 
allowed to settle into position for a few hours. 
4. Dry ice is applied for 5 seconds to the exposed site in the nuchal 
area. 
5. On a circular (0 2 cm) filter paper 0.2 ml of the test substance 
in petrolatum is dispensed and the ointment is applied through the 
window, with the edges of the filter paper tucked under the dressing. 
6. The window is occluded with impermeable adhesive tape (Leukosilk, 
Beiersdorf, FRG). 
Day 2 : The window covering and the filter paper are removed and steps 5 and 
6 of day 0 are repeated. 
Day 4 : After removing the window covering and the filter paper two 0.1 ml 
intradermal injections of Freund's complete adjuvant/saline (50/50 
v/v) are given on either side in the epicutaneously exposed nuchal 
area. Thereafter steps 5 and 6 of day 0 are repeated. 
Day 7 : The procedure of day 2 is repeated. 
Day 9 : All dressings are removed. 
Day 21: An open epicutaneous challenge is performed with a non-irritant 
concentration of the test substance in petrolatum as a vehiculum; 
0.1 ml is rubbed in, with a gloved finger, on 2 cm2 of the clipped 
left flank of the guinea pig. Reactions are read after 24, 48, 72 and 
96 hrs. 
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Day 35: The procedure of day 21 is repeated on other sites of the left flank 
of the guinea pig. Only for acrylamide a closed patch test is performed, 
using Silver patches (89) and a Coban occlusive dressing. Amount, 
concentration and vehiculum are identical to the open applications. 
After 24 hrs the dressings and the Silver patches are removed. 
Day 49: Repetition of the procedure of day 21, again using the left flank. 
In addition the test substance is tested in another vehiculum. 
Ν,Ν'-methylene bis acrylamide is tested in ethanol/distilled water 
(80/20 v/v), N-dodecyl maleamic acid is not tested in another vehiculum. 
All other substances are tested in Aramek. 
Day 63: Cross-reactivity of the sensitized animals is determined by open 
applications in petrolatum on the right flank. Concentrations are 
identical to the highest ones, used in the challenges. The original 
sensitizing substance is always retested. Only those animals who still 
reacted to that substance are included. Control animals, who had also 
received 2 Freund's complete adjuvant injections on day 4, are also 
tested. 
Criteria for sensitization are described in chapter 3.2. In advance of all 
experimental procedures the maximal non-irritant concentration for open 
epicutaneous application was estimated on 4 untreated guinea pigs, not participa­
ting in the induction procedure. This was done both with petrolatum and with 
Aramek as a vehiculum. With petrolatum the maximum elicitation concentration 
was limited to that concentration which could be spread easily with good ad­
herence to the guinea pig skin. 
3.3.2. Results 
No irritant reactions were observed to any of the substances in the tested 
concentrations. In addition to the highest concentration, a concentration 3 
times and 10 times lower was tested in the challenges. The 2 higher con­
centrations in petrolatum and the highest concentration in Aramek were applied 
in the challenges. Only the results of the guinea pigs to the highest con­
centrations used for challenges are shown in Tables 3 and 4. 
In the Freund's Complete Adjuvant Test (Table 3) with an induction con­
centration of 0.5 M, acrylamide and N-hydroxymethyl acrylamide appeared to be 
moderate sensitizers, according to the classification of Magnussen & Kligman 
(85). The incidence of sensitizations on day 35 was used for this grading. 
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TABLE 3: Results of the Freund's Complete Adjuvant Test 
Substance Number of Induction Challenge Number of 
animals concentration concentration* sensitized animals 
day 21 day 35 
Acrylamide 
controls 
Methacrylamide 
controls 
N-hydroxymethyl 
acrylamide 
controls 
8 
4 
8 
4 
8 
4 
0.5 M (=3.5%) 
0.5 M (=4.2%) 
0.5 M (=5.0%) 
0.3 M 
0.3 M 
0.3 M 
0.3 M 
o.i M 
0.1 M 
4/8 
0/4 
0/8 
0/4 
1/8 
0/4 
3/8 
0/4 
0/8 
0/4 
4/8 
0/4 
*0pen epicutaneous applications in Aramek. 
Methacrylamide in the same induction concentration did not sensitize any of 
the tested animals. 
With one exception no cross-reactions were observed in the sensitized 
animals to the substances listed in Table 5. One animal, sensitized to 
N-hydroxymethyl acrylamide showed a cross-reaction to acrylamide. 
In the Split Adjuvant Test (Table 4) acrylamide, N-hydroxymethyl acryl­
amide and Ν,Ν'-methylene bis acrylamide were moderate sensitizers according 
to the same above-mentioned classifications (85). The incidence of sensitiza­
tions on day 35 was used for this grading. For all 3 substances no positive 
reactions were observed in the challenge on day 21. With N-hydroxymethyl 
acrylamide a somewhat higher incidence of sensitizations was observed with 
Aramek as a vehiculum in the challenge. The substances methacrylamide, 
N-dodecyl maleamic acid appeared to be weak sensitizers with this test method, 
while N-t-butyl acrylamide did not sensitize a single animal. 
Only one animal showed cross-reactions to the substances, named in Table 5. 
This guinea pig, sensitized to Ν,Ν'-methylene bis acrylamide cross-reacted 
to maleamic acid, acrylamide and N-hydroxymethyl acrylamide. The animals 
sensitized to one of the two alkyl maleamic acids were tested for cross-
reactions with the substances listed in Table 6 in their respective con­
centrations in petrolatum. No cross-reactions to these substances were 
observed. 
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TABLE 4: Results of the Split Adjuvant Test. 
Substance 
Acrylamide 
controls 
Methacrylamide 
controls 
N-hydroxymethyl 
acrylamide 
controls 
N,N'-methylene 
bis acrylamide 
controls 
N-t-butyl 
acrylamide 
controls 
Number of 
animals 
10 
6 
10 
6 
9 
6 
10 
6 
10 
6 
N-t-butyl maleamic 8 
acid 
controls 4 
Induction1 
concentration 
3 M (=21%) 
3 M (-25%) 
2.5 M (=25%) 
2 M (=31%) 
2 M (=25%) 
2.5 M (=43%) 
Challenge 
concentration 
3 
0.3 
3 
0.3 
3 
0.3 
3 
0.3 
2.5 
0.1 
2.5 
0.1 
2 
0.3 
2 
0.3 
2 
0.3 
2 
0.3 
2.5 
0.1 
2.5 
0.1 
M 1 
M 3 
M 1 
M 3 
M 1 
M 3 
M 1 
M 3 
M 1 
M 3 
M 1 
M 3 
M 1 
M" 
M 1 
м
ц 
M 1 
M 3 
M 1 
M 3 
M 1 
M 3 
M 1 
M 3 
Number of 
sensitized animals 
day 21 day 35 day 49 
0/10 
NT 
0/6 
NT 
0/10 
NT 
0/6 
NT 
0/9 
NT 
0/6 
NT 
0/10 
NT 
0/6 
NT 
0/10 
NT 
0/6 
NT 
1/8 
NT 
0/4 
NT 
5/102 
NT 
о/б2 
NT 
1/10 
NT 
0/6 
NT 
3/9 
NT 
0/6 
NT 
4/10 
NT 
0/6 
NT 
0/10 
NT 
0/6 
NT 
1/8 
NT 
0/4 
NT 
5/10 
5/10 
0/6 
0/6 
1/10 
1/10 
0/6 
0/6 
2/9 
4/9 
0/6 
0/6 
4/10 
2/10 
0/6 
0/6 
0/10 
0/10 
0/6 
0/6 
1/8 
2/8 
0/4 
0/4 
N-dodecyl maleamic 10 
acid 
controls 6 
1 M (=28%) 1 M 1 
ι n'­
ozio 
0/6 
2/10 
0/6 
1/10 
0/6 
in petrolatum; closed challenge; in Araraek; in ethanol/water 
(80/20 v/v) . 
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TABLE 5: Structure formulas of the test substances used to determine the 
cross-reactivity of animals, sensitized to any of the acrylamides. 
Acrylamide : H C=CH-C-NH 
О 
I  
Methacrylamide : H C=C-C-NH 2 
сн3 
О 
II 
N-hydroxymethyl acrylamide : H C=CH-C-NH-CH 2OH 
О О 
Il II 
Ν, N'-methylene bis acrylamide: H 2OCH-C-NH-CH 2-HN-C-CH=CH 2 
Maleamiс acid HO· 
0 
II 
-c-
0 
II 
-HC=CH-C-NH2 
0 
Й 
Η с=сн-с-
сиз 
-NH-C-CH, 
сн3 
N-t-butyl acrylamide 
TABLE 6: Structure formulas of the test substances used to determine the cross-
reactivity of animals, sensitized to any of the alkyl raaleamic acids. 
N-t-butyl maleanuc acid : HO-C-HC=CH-C-NH-C-CH, 
I J 
4 
3 
О 0 CH 
II I 
-c 
I 
CH 
3 
N-dodecyl maleamic acid : HO-C-HC=CH-C-NH-C Η,ς 
О О 
Il II 
Maleamic acid : HO-C-HC=CH-C-NH 2 
0 CH·, 
N-t-butyl acrylamide : H2C=CH-C-NH-C-CH3 
сн3 
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3.3.3. Discussion 
In a pilot study in our laboratory we did not observe allergic reactions 
in guinea pigs, induced with acrylamide, N-t-butyl acrylamide or t-butyl 
maleamic acid. In this pilot study with θ experimental and 4 control animals 
for each substance, we used the Freund's Complete Adjuvant Test with an in­
duction concentration of 0.1% (w/v) for all 3 substances. The poor solubility 
of especially N-t-butyl maleamic acid in both water and paraffin oil forced 
us to use this low induction concentration. To obtain a higher yield of 
sensitizations we decided to apply the more time-consuming Split Adjuvant 
Test, in which higher induction concentrations could be used. For comparison 
purposes the water-soluble test substances, i.e. acrylamide, methacrylamide 
and N-hydroxymethyl acrylamide, were also investigated in the Freund's 
Complete Adjuvant Test using a equimolar induction concentration. We did not 
use the same induction concentration on a molar basis for all substances in 
the Split Adjuvant Test. Instead we used the highest concentration in petro­
latum which could be spread easily with good adherence to the guinea pig 
skin. This might be a draw-back in comparing the sensitizing capacities of 
the tested chemicals. However, we feel that in case of induction by epicutaneous 
application of the allergen the influence of the vehicle on the actual dose, 
i.e. the dose penetrating through the skin, is very great. With higher con­
centrations than applied by us, the properties of the ointment change drastic­
ally. So, using the same high concentration for all substances would create 
a false sense of mutual comparability in our opinion, while lowering all con­
centrations for all substances would unduly dimmish the yield of sensitiza­
tions of the test for those, sufficiently stable in the higher concentrations. 
In our experiments a good correlation was found between the results ob­
tained in the Freund's Complete Adjuvant Test and those in the Split Adjuvant 
Test. In one article (45) the Split Adjuvant Test was reported to be only 
slightly inferior to the Guinea Pig Maximization Test and better than the 
other 9 investigated animal tests. Tests in which the application of Freund's 
Complete Adjuvant is part of the induction procedure, appear to be superior 
to the other, non-adjuvant tests (101). 
The challenges on day 35 and day 49 frequently resulted in higher numbers 
of sensitized animals than the challenge on day 21. This is suggestive for a 
function of the challenge on day 21 in inducing sensitization by both methods 
used. 
In the comparison between the 2 published reports on human sensitizations 
4Θ 
to pressure-sensitive adhesives (73, 66) some discrepancies are noted. Jordan 
(73) stated that N-t-butyl maleamic acid was present in the Curad adhesive, 
whereas Heskel et al. (66) contended that only alkyl maleamic acid was present, 
in which the alkyl group ranged from 8 to 16 carbon atoms. A patent, assigned 
to the producer of Curad, describes the application of N-t-butyl maleamic acid 
as a copolymer in the production of a porous pressure-sensitive adhesive 
(111). However, changing the chemical composition of a product without changing 
the name of that product is not uncommon in industry. This may be an explana-
tion for the different statements regarding the chemical composition of Curad 
adhesive in the 2 reports. Unfortunately Heskel et al. (66) did not test their 
2 patients with N-t-butyl maleamic acid. 
The cross-reaction pattern of the patients described in these 2 reports 
(73, 66) cannot be simply compared with each other since the tested substances, 
the vehicles and the concentrations were not the same. Jordan (73) did not 
observe cross-reactions to N-t-butyl acrylamide (5% in petrolatum), but only 
to several other acrylate esters. No other acrylamides were tested by him. 
2-EHA (4.8% in petrolatum) gave negative results in the 2 patients of Heskel 
et al. (66). They (66) observed cross-reactions to N-octadecyl maleamic acid 
(1%) and to octyl maleic acid ester (1%) with a remarkable vehicle specificity: 
the former substance elicited positive reactions in water/isopropanol (50/50) 
but not in petrolatum, while the reverse was observed for the latter substance. 
Such a vehicle specificity was also noted in an experimental study of B^örkner 
and Niklasson (16). They observed more allergic reactions to acrylate monomers 
when the guinea pigs were challenged with the monomer in petrolatum as a 
vehicle than when challenged with acetone as a vehicle. By means of HPLC-
analysis of these solutions they showed that this phenomenon was due to a 
rapid polymerization of the monomer in acetone, resulting in false-negative 
responses because of too low an actual concentration of the monomer. 
In our animal experiments both N-t-butyl maleamic acid and N-dodecyl 
maleamic acid were weak sensitizers in the Split Adjuvant test. A cross-
reactivity could not be detected, but only 2 animals were available for the 
determination of the cross-reactivity. On the basis of our results no preference 
can be given for one of these alkyl maleamic acids with respect to their 
sensitizing potential in animals. Of the acrylamides 3 substances appeared to 
be moderate sensitizers, viz. acrylamide, N-hydroxymethyl acrylamide and 
Ν,Ν'-methylene bis acrylamide. Human sensitizations to these substances are 
reported: Fregert and Dahlquist (54) described a worker m the plastic 
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industry, who appeared to be sensitized to N-hydroxymethyl acrylamide. Malten 
et al. (91) described 2 patients sensitized after handling Nyloprint printing 
plates. Both patients showed positive reactions when patch-tested with Ν,Ν'-
methylene bis acrylamide (5% in ethanol), and one patient also reacted to 
N-hydroxymethyl acrylamide (1% in water) and to acrylamide itself (5% in 
water). Pedersen et al. (121) noted that his 7 patients, sensitized to Nylo­
print, were all positive to NfN'-methylene bis acrylamide, 6 also to N-hydroxy­
methyl acrylamide and 2 to acrylamide. Since they could not detect the latter 
2 substances in the Nyloprint plates, they suggested that cross-allergy was 
responsible for the positive results to these substances. In our animal 
experiments we only observed cross-reactions to other acrylamides in 2 out of 
18 animals sensitized to one of the acrylamides. 
The absence of reports of clinical sensitizations to methacrylamide or 
N-t-butyl acrylamide correlates well with our findings in the guinea pigs. 
The well-known neurotoxicity of acrylamide (117) remains the prime reason 
for keeping the concentration of this monomer in endproducts as low as possible. 
However, if a person is sensitized to acrylamide even a dose of monomenc 
acrylamide substantially below the minimum dose to elicit neurotoxic symptoms, 
might be high enough to provoke an allergic contact dermatitis. At present 
the use of acrylamides in pressure-sensitive adhesives does not seem to be 
associated with great allergological risks. Our results suggest that if 
dermatological problems occur, replacement by methacrylamide or N-t-butyl 
acrylamide might be considered. When 2-EHA would cause sensitizations to 
pressure-sensitive adhesives, replacement by pentyl methacrylate might be a 
solution. Pentyl methacrylate appeared to be a non-sensitizer in guinea 
pigs (156). 
3.4. a.,e,-DIACRYLOXYPROPIONIC ACID, A SENSITIZING IMPURITY IN COMMERCIAL 
ACRYLIC ACID 
3.4.1. Introduction 
II 
The presence of carboxyl groups (-C-OH) m adhesives and dental filling 
materials improves adhesion to substances such as metals, nylon, enamel and 
dentin (96, 115). Therefore acrylic acid is frequently used as a copoly-
menzing monomer in the production of pressure-sensitive adhesives; other 
uses of acrylic acid are described in chapter 1.2.2. Van der Walle et al. 
(156) obtained a strong allergic response in guinea pigs to a commercial 
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sample of acrylic acid. No reactions were observed to a distilled sample 
of acrylic acid. This pointed to a strongly sensitizing impurity in this 
commercial grade acrylic acid. Should this impure acrylic acid be further 
used to produce a variety of endproducts, these endproducts might still 
contain this sensitizing substance. Especially when used in adhesives meant 
for application on the human skin, the risk of sensitization to this impurity 
would be considerable. 
Therefore we decided to try to isolate and identify this sensitizing 
substance by a combination of chemical analysis (Drs. E. Seutter) and a bio-
assay with guinea pigs. The latter bio-assay also gave us the opportunity 
to look for possible cross-reactions of the sensitized animals to related 
compounds. 
3.4.2. Materials and methods 
ohemioals 
Samples of acrylic acid were obtained from various sources: Merck Schuchardt 
(FRG), Aldrich (Belgium) and BDH (England). After a complaint on the impurity 
of the sample obtained from Merck Schuchardt we received from that supplier 
a second sample with a gas chromatogram, illustrating its purity (better than 
99%) . Diazald (N-methyl-N-mtroso-p-toluenesulfonamide, precursor to diazo-
methane) , e-caprolactam, 4-methoxyphenol, methacrylic acid, 2,2-d:Lmethoxy-
propane and glyceric acid were obtained from Aldrich, while 4-toluenesulfonic 
acid, diethylether, methanol and inorganic chemicals were analytical grade 
Merck products. Hexyl acrylate and 1,2-ethanediol diacrylate were obtained 
from Polyscience Inc. (USA). Freund's Complete Adjuvant was from Difco Lab. 
(USA) . 
chemical preparations 
Methylation was performed either by diazomethane in ether or by 2,2-di-
methoxypropane in methanol with a catalytic amount of 4-toluenesulfonic acid, 
followed by evaporation in vacuo. Hydrolysis of the esters was performed by 
heating one hour with excess of NaOH in water, acidifying with HCl and 
evaporating in vacuo. 5-Hexenoic acid was prepared from ε-caprolactam 
according to Linstead and Rydon (82). 
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gas chromatography 
Analytical gas chromatography (g.с.) was performed with a Hewlett Packard 
402 gas Chromatograph with integrator 3373 В flame-ionization detector and 
nitrogen as a carrier (2,5 cm3.min-1) with 6' columns containing 5% silicone 
OV 101 or 5% silicone OV 17 on Gaschrom Q. Preparative gas chromatography 
was performed with a Hewlett Packard 700 instrument with thermal conductivity 
detector and helium as a carrier (30 cm3 .min-1) on 6' columns containing 5% 
silicone OV 101 on Gaschrom Q. The Standard program was 70-300oC at 7.5°C 
min - 1, injection port 80eC, detector 3250C. Fractions from preparative gas 
chromatography were collected in cooled glass tubes. 
spectra 
Mass spectra were obtained with a LKB gas Chromatograph mass spectrometer 
9000 at 150oC ion source temperature and 20 eV (ion source pressure I.S-IO"1* 
Pa) or with a Varían SM lb at 130"С ion source temperature and 70 eV. 
animals 
Female guinea pigs of the Hartley outbred strain (Broekman Institute, The 
Netherlands), weighing approximately 400 g at the beginning of the study, 
were used for the sensitization experiments. They were housed in pairs in 
steel cages with free access to water and pellet food (Hope Farms, The Nether­
lands) . 
sensitization procedures 
The modified Freund's Complete Adjuvant Test with identical challenge 
procedures and identical criteria for sensitization was used as described 
in chapter 3.2.1. A maximal non-irritant concentration of the test substances 
in Aramek was estimated as described in chapter 3.3.1. This maximal non-
irritant concentration and 2 lower concentrations were used in the challenges. 
Groups of θ animals each were induced with one of the following substances: 
the first impure Merck Schuchardt sample of acrylic acid, 5-hexenoic acid 
(confer results) from our own synthesis and α,Β-diacryloxypropionic acid 
(DAPA), obtained by distillation in vacuo of the first Merck Schuchardt acrylic 
acid sample. These test substances were mixed each with distilled water to a 
concentration of 0.34 M and to this solution an equal volume of Freund's 
Complete Adjuvant was added and mixed well. Because of a severe ulceration 
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at the site of the first injection with DAPA we were forced to change the 
induction procedure for the animals of this group. After intradermal injection 
at day 0 these animals received on day 7, also m the nuchal area, a 0.1 ml 
intradermal injection of Freund's Complete Adjuvant without test substance, 
together with a single open epicutaneous application of 0.025 ml of a 0.3 M 
solution of DAPA on the site of this latter injection. No injections were 
given in animals of this group on day 5 or 9. 
The inhibitor 4-methoxyphenol, which had been added to all acryl con-
taining substances under investigation to prevent polymerization was tested 
m all animals on day 49 in a 1 M concentration. Cross-reactions to other 
acryl containing compounds were investigated on day 63 in the sensitized 
animals with the same method as used in the challenges. 
3.4.3. Results 
In the first Merck Schuchardt sample analytical gas chromatography on the 
OV 101 phase of samples of acrylic acid showed a large fraction in addition 
to the acrylic acid fraction, with a peak area ratio of 2:3 and a number of 
smaller peaks. In the Aldrich and BDH products no deviations from the purity 
specified by the manufacturer (99%) were observed. 
Preparative gas chromatography of the impure Merck Schuchardt product gave 
the same m a m fractions. Using this technique it was evident that part of the 
substance introduced on the column decomposed and part of it was retained 
and could only be removed by long heating. Of the smaller fractions, obtained 
by preparative gas chromatography, the largest one, after methylation, could 
be identified by gas chromatography mass spectrometry as hexenoic acid, pre-
sumably 5-hexenoic acid. 
Upon vacuum distillation of the large unidentified fraction a distillate 
was obtained, boiling both at 145CC-1.6 kPa and at 88-89*^-0.13 kPa, which 
always partly decomposed during distillation into acrylic acid. When the 
latter distillate was methylated, we obtained a stable ester. With vacuum 
distillation of this ester we got a distillate, boiling at 95-96.50C-1.6 kPa, 
that in analytical g.c. was stable on the OV 101 phase and better than 99.5% 
pure, but which was unstable on the OV 17 phase. Its mass spectrum showed a 
small parent mass at m/e 228. 
Upon complete hydrolysis of this ester acrylic acid could be removed and 
a syrup remained, that, after methylation, showed the same decomposition 
pattern in the g.c. as methylated glyceric acid. Hence, the unknown compound 
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in this commercial acrylic acid sample was glyceric acid, esterifled with 
2 molecules of acrylic acid. The reaction scheme we followed is shown m 
Scheme 1. 
Scheme 1 
CH.=CH-C-0-CH„ 2 | 2 
CH„=CH-C-0-CH 2
 II I 
0 COOH 
I 
(сн3)2с(0СНз)2 
CH
n
=CH-C-0-CH. 
2 ι ¿ 
CH =CH-C-0-CH 
2
 II I 
0 
II 
COOH., 
hydrolysis 
2 CH2=CH-COOH 
IV + 
HOCH0-CH-COOH ¿
 I 
OH 
III 
methanol 
Reaction scheme in the identification of a, ¡3-diacryloxypropionic 
acid (DAPA). I = α,ß-diacryloxypropionic acid; II = methyl diacryl-
oxypropionate; III = glyceric acid; IV = acrylic acid. 
The second sample of Merck Schuchardt acrylic acid, given to us with a 
gas chromatogram suggesting this sample was better than 99% pure, was subjected 
to vacuum evaporation and subsequent methylation of the residue. The amount 
of DAPA in this acrylic acid sample proved to be 7%. The BDH and Aldrich 
samples of acrylic acid, when treated in the same way, did not give any 
specific secondary product. 
The results of the guinea pig experiments are summarized in Table 7 and 
show that both the Merck Schuchardt acrylic acid and DAPA, isolated from it, 
are strong sensitizers m the guinea pig. 5-Hexenoic acid was not a sensitizer. 
When using the same solvent (Aramek) and the same application method (open), 
the irritant potential of DAPA on the guinea pig skin was approximately 
equal to that of diacrylate esters, which are known irritants to the human 
skin (92). All animals, sensitized to the acrylic acid sample reacted to the 
0.03 M solution of DAPA, but not to a 1 M solution of distilled acrylic acid. 
All animals, sensitized to DAPA reacted to a 1 M solution of Merck Schuchardt 
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TABLE 7: Sensitizing potential in the modified Freund's Complete Adjuvant Test. 
Test substance Induction Challenge 
concentration* 
Number of sensitized animals/ 
number of tested animals 
day 21 day 35 day 49 
Acrylic acid, 
from Merck Schuchardt 
α,β-Diacryloxypropionic acid 
5-Hexenoic acid 
н2с=сн-(сн2)3-соон 
Controls 
3-0.17 M 
(=1.2%) 
1-0.17 M** 
(=3.6%) 
3-0.17 M 
(=1.9%) 
3-FCA/dist. 
water 
1 M 
0.3 M 
0.03 M 
o.oi м 
3 M 
1 M 
all the above 
compounds 
8/8 
1/8 
8/8 
7/8 
0/8 
0/8 
0/8 
8/8 
NT 
NT 
7/8 
0/8 
0/8 
0/8 
NT 
7/8 
NT 
7/8 
0/8 
0/8 
0/8 
NT = not tested. 
* In Aramek, 2 parts methyl ethyl ketone, one part peanut oil by volume. 
** Different induction procedure (see Materials and Methods) . 
TABLE 8: Cross-reactions of sensitized animals to related compounds. 
Test substance Structure formula Challenge Animals sensitized to 
concentration* Merck Schuchardt o,3-diacryloxy-
acrylic acid propionic acid 
Acrylic acid (distilled) 
Hexyl acrylate 
Methacrylic acid 
н2с=сн-соон 
0 
II 
H с=сн-с-о-(си )5-сн3 
H,C=C-COOH 
¿
 I 
сн^ 
о 
II 
1,2-Ethanediol diacrylate H_C=CH-C-0-CH_ 
2 , 2 
н„с=сн-с-о-сн„ 
2 ι, 2 
1 M 
(=7.2%) 
1 M 
( = 15.6%) 
ι м 
(=8.6%) 
0 . 0 3 M 
(=0.5%) 
0/7 
0/7 
0/7 
0/7 
0/7 
0/7 
0/7 
0/7 
О 
II 
Methyldiacryloxypropionate H_C=CH-C-0-CH_ 
2 I 2 
н„с=сн-с-о-сн 
2
 H I 
О COOCH, 
0.03 M 
(=0.5%) 
5/7 4/7 
In Aramek (2 parts methyl ethyl ketone, 1 part peanut oil by volume). 
acrylic acid, but not to a 1 M solution of distilled acrylic acid or acry-
lic acid obtained from Aldrich or BDH. No reactions were observed to 4-methoxy-
phenol, except in one animal induced with impure acrylic acid. Results of 
the tests on cross-reactions are represented in Table 8: none of the sensitized 
animals reacted to hexyl acrylate, methacrylic acid or 1,2-ethanediol di-
acrylate. The methyl ester of the sensitizer gave positive reactions in the 
majority of animals sensitized to the parent a,3-diacryloxypropionic acid. 
3.4.4. Disaussion 
The remarkable difference in the purity of acrylic acid, as specified by 
Merck Schuchardt and the purity observed by us may be ascribed to the use of 
different phases in analytical gas chromatography. In quality control by 
analytical g.c. mostly a phase is chosen which is good at separating the sub-
stance under investigation from its homologues or similar compounds. However, 
in the case of acrylic acid such a phase is not capable of detecting DAPA, due 
to retention and decomposition of the latter compound on the column. On our 
own columns retention and decomposition only occurred partially, so we could 
detect DAPA, although we could not make a reliable estimation of the purity 
of the acrylic acid samples by g.c. 
The presence of hexenoic acid may indicate the reaction from which the DAPA 
originates. A patent (12) describes the manufacture of 5-hexenoic acid from 
acrylic acid, propene, water, benzene and hydroquinone at 200°C. This suggests 
the technical synthesis of acrylic acid by catalytic oxidation of propene, 
a patented way of producing acrylic acid (115). A possible side-product of 
this oxidation is 2,3-epoxypropionic acid, that will react with the acrylic 
acid present in excess (Scheme 2). 
The results of the guinea pig experiments demonstrate that DAPA is the cause 
of the allergic response to commercial grade acrylic acid manufactured by 
Schuchardt. It is rather unusual to discover an impurity in a substance by 
testing this substance in an animal sensitization test. However, this 
illustrates the detection sensitivity of the Freund's Complete Adjuvant Test. 
The observed scant cross-reaction pattern is in accordance with published 
results (157). We may draw 2 conclusions from this study: 
1. Quality control by gas chromatography is not always a guarantee that 
a product does not contain considerable amounts of by-product(s). 
2. Acrylic acid, in itself not allergenic, may contain a strongly sensitizing 
impurity, which can be removed by distillation. Unfortunately, not all 
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manufacturers perform this simple action. Purity of the product is 
important when acrylic acid is used as a copolymer in the production 
of acryl-based adhesivas, lacquers and dental filling materials (96). 
Scheme 2 
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Supposed origin of α,ß-diacryloxypropionic acid in the production 
of acrylic acid. I and IV see Scheme 1; V = propene; VI = 2,3-
epoxypropionic acid. 
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C H A P T E R 4 
PERMEABILITY OF SURGEONS1 GLOVES TO METHYL METHACRYLATE, 
BUTYL ACRYLATE AND ACRYLAMIDE 
4.1. INTRODUCTION 
For the prevention of occupational skin disorders a choice can frequently 
be made out of an arsenal of possibilities (87) . It is widely recognized 
that technical preventive measures {e.g. production in closed systems, 
mechanical ventilation etc.) are preferable to personal preventive measures 
(e.g. the wearing of masks, or gloves, application of barrier creams). 
Technical preventive measures can be better controlled and are less dependent 
on the cooperation of the workers involved. Technical prevention starts with 
the choice of the right material. Therefore newly introduced materials should 
be tested adequately for their toxicological behaviour in several biological 
test systems before they come into use. Examples of such investigations on 
acrylic monomers are the theses of Van der Walle (15Θ) and Bjôrkner (15). 
Based on the results of such investigations technical measures can be 
taken and processing instructions can be given for every situation in which 
the new material is used. Unfortunately technical preventive measures cannot 
always be taken, sometimes because costs being too high, sometimes because 
of interference with the production process. In such cases personal preventive 
measures become necessary and inevitable. 
The wearing of gloves is a personal preventive measure, which is meant to 
protect the skin against contact and subsequent absorption of noxious sub-
stances. This simple method is only adequate for short-term use, since the 
wearing of protective gloves during longer periods of the day is both im-
practicable and undesirable. Moreover the gloves should be clean, not damaged 
and they should be impermeable to the noxious substance. When the gloves do 
not come up to the latter requirement, a potentially dangerous situation 
exists. Then, the gloves will serve as an occlusive dressing and the ab-
sorption of the substance, penetrated through the gloves, will be enhanced, 
instead of prevented. The penetration of the given substance through the 
gloves also involves the risk that constituents of the gloves will be 
liberated with greater ease and will come into contact with the skin in 
greater amounts. In addition, the use of gloves may give a false sense of 
safety to the wearer and, possibly, a less clean way of working. 
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Therefore it is very important to test gloves for permeability to the 
substances against which they should offer protection. Several allergens are 
known to be able to penetrate through gloves (108). When an occupational 
exposure to an allergen occurs, adequate protection is even more urgently 
needed. 
In the operating theatre the wearing of gloves, often during several hours, 
is unavoidable for reasons of asepsis. Only rubber gloves are employed 
usually. This means that if surgical personnel is exposed to a substance 
penetrating their gloves, these people run the risk of sensitization both 
to the penetrating substance and to the rubber auxiliary chemicals which are 
present in every rubber glove. Methyl methacrylate is used in orthopaedic 
surgery as a bone cement, particularly for the fixation of hip and knee endo-
prostheses. Contact sensitizations to methyl methacrylate used in the 
operating theatre have been described, even sensory neuritis, affecting those 
parts of the hands, most exposed to the acrylic cement. Recovery from the 
sensory neuritis takes several months (50) and an allergic contact sensitivity 
may stay on for years, if not for lifetime. 
It is possible to distinguish several consecutive phases in the develop-
ment of an allergic contact dermatitis, viz. a) induction, b) clinical 
manifestation, c) clinically silent sensitization with recurrences after un-
expected exposure. Factors which play an important role in induction are: 
(physico) chemical and immunochemical properties of the contactant, con-
centration, vehicle, route of administration, duration, extension and the 
repetition of exposure, quality, health and protection of the exposed skin, 
proneness of the exposed organism to respond to stimulation with the formation 
of T-effector and T-repressor cells. In view of these facts, we may all be 
regarded as being on our way to become (contact) sensitized to one substance 
or another. Which substance will be "our" contact sensitizer depends on our 
pattern of life, resulting in a number of inevitable exposures. Whether such 
exposure has grave consequences depends on the possibility of replacing "our" 
contact allergen. 
For an orthopaedic surgeon this means that he is on his way to develop 
contact sensitization to methyl methacrylate or other sensitizing components 
m the bone cement he uses, to rubber additives, etc. Nobody is able to detect 
how far he has already gone in the direction of sensitization, and how far 
he still has to go before sensitization becomes clinically apparent. The only 
way in which he may delay this disaster is by using a concentration of the 
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contact allergen as low as possible, to shorten each possible exposure, to 
protect the skin and keep it in good health. 
The incidence of contact sensitizations among orthopaedic surgeons at 
present is not of great importance, but the expected incidence is to be feared. 
Due to the phenomenon of group-specificity it is to be expected that an 
individual, sensitized to methyl methacrylate will also react to quite a 
number of different acrylics (52), so that no allergen replacement is possible, 
and the surgeon must stop cementing endoprostheses. In addition, he will run 
a risk of recurrences of his dermatitis as a result of exposure to acrylics 
used for various purposes in everyday life (15Θ). 
The incidence of contact sensitization to rubber chemicals is so high in 
the general population that some 16 of them have been incorporated in the 
screening series of contact allergens of the International Contact Dermatitis 
Research Group (89). The frequency with which allergen replacement is demanded 
by surgeons indicates that contact sensitizations to these auxiliary sub­
stances are frequent among them. In addition it can be rather serious if re­
placement has become really impossible in certain cases, because the store 
of alternatives has been exhausted due to the development of contact 
sensitization to all rubber additives which are commonly used in the produc­
tion of surgical gloves. To ease the urge for allergen replacement in cases 
of "glove" sensitization, it was Hjorth (67) who incited production of so-
called "Elastyren" gloves, containing an auxiliary substance of low sensitiz­
ing capacity. 
It has been demonstrated that methyl methacrylate easily penetrates the 
usual rubber gloves, whereas in thick vinyl gloves permeation of methyl meth­
acrylate could not be detected (122). However, the use of thick gloves is in­
convenient for surgeons. To quantify these findings, we designed a test system 
in which we examined the permeability to methyl methacrylate of a collection 
of surgeons' gloves from our hospital, and of some gloves made of alternative 
materials. In addition, the same test method was applied in preliminary 
studies on the penetration of butyl acrylate and acrylamide through some 
gloves. The latter 2 acrylic monomers were selected because of their industrial 
importance. 
61 
4.2. MATERIALS AND METHODS 
ahemiaals 
Methyl methacrylate, butyl acrylate (Merck-Schuchardt), ethanol, methanol 
(Merck p.A.) and butanone-2 (B.D.H.) contained no impurities interfering with 
the analyses. Acrylamide (Aldnch) was recrystallized 3 times from methanol. 
Neopentyl alcohol (Aldrich), л-pentanol (B.D.H.) and octanol-2 (Merck) were 
fractionated before use. 
samptes 
We collected 7 surgeons' gloves (nos. 1-7), 3 examination gloves (nos. 
8-10) and a household glove (no. 11) (Table 1). To check the resistance of 
the glove materials to undiluted methyl methacrylate, samples, taken from the 
fingers of the gloves were soaked in undiluted methyl methacrylate for 1 h. 
Samples for permeation and density measurements were taken from the wrists of 
the gloves. In advance of the measurements, powder was removed by rinsing 
with ethanol and subsequent drying at ambient temperature. 
diffusion ohamber 
The chamber consisted of two square blocks of glass in which cylindrical 
apertures had been made, closed on one side with glass. Holes drilled in the 
blocks made it possible to screw them together, using screws furnished with 
rubber 0-rings. Samples were placed vertically between flat rubber rings 
(from which soluble material had been removed by soaking in butanone-2 for 
several days and drying), fitting to the flat areas surrounding the cylindrical 
apertures. Both compartments of the chamber could be reached through glass-
stoppered connections to holes drilled in the walls of the cylinders. The 
compartments could contain a volume of 5.75 ml; the available glove sample 
area was 3.14 cm2. The contents of the compartments were stirred magnetically. 
The chamber was placed in a double-walled beaker. Water was pumped from a 
thermostat through the space in the wall. The beaker was covered with a sheet 
of foam plastic with holes for the glass-stoppered connections, and a control­
ling thermometer to regulate the temperature in the beaker. Experiments were 
performed at 21.0±0.5oC, and 35.0±0.5,,C. Liquids were heated to these 
temperatures before introduction. 
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analyses 
For the experiments with methyl m e t h a c r y l a t e a n a l y s e s were performed with 
a Hewlett Packard 402 gas Chromatograph w i t h i n t e g r a t o r 3373B, flame i o n i z a ­
t i o n d e t e c t o r and nitrogen c a r r i e r ( 2 . 5 cm3 . m m - 1 ) on a 6 ' g l a s s column con­
t a i n i n g 4.7% s i l i c o n e OV 210 on Gaschrom Q. I n an i sotherm programme tempera­
t u r e s were: i n j e c t i o n port 40oC, oven 4 3 0 C , d e t e c t o r 59 0 C. Mean r e t e n t i o n 
times were: e thanol 50 s, neopenty l a l c o h o l 125 s, methyl methacry la te 200 s, 
я-pentanol 285 s . In the s o l u t i o n s n e o p e n t y l a l c o h o l served as an i n t e r n a l 
standard t o c o r r e c t p i p e t t i n g e r r o r s ; 72-pentanol had been added t o prevent 
t a i l i n g of the methyl methacrylate p e a k . 
Of standard s o l u t i o n s of methyl m e t h a c r y l a t e in e t h a n o l , conta in ing 22.7 
mM neopentyl a lcohol and 22.7 mM 72-pentanol , 1 μΐ samples were analysed. The 
e r r o r s were: 1 mM: 10%,2-5 mM: 3.5%, 6-150 mM: 1%, 160-600 mM: 4%. A c a l i b r a ­
t i o n curve was obtained that d i f f e r e d s l i g h t l y from l i n e a r . In t h e d i f fus ion 
chamber one compartment was f i l l e d w i t h a b l a n k s o l u t i o n : e t h a n o l , c o n t a i n i n g 
22.7 mM neopentyl a lcohol , and 22.7 mM n - p e n t a n o l . The o t h e r was f i l l e d with 
4.7 M (50% w/v) methyl methacrylate in e t h a n o l w i t h t h e same a d d i t i o n s . 
At the moment of f i l l i n g the l a t t e r compartment, a stopwatch and magnetic 
s t i r r i n g were s t a r t e d . Eight t o t w e l v e 1 y l samples from t h e former compart­
ment were analysed as a function of t ime w i t h i n 90 m m . Then t h e column was 
cleaned by h e a t i n g t o 250oC. 
Each experiment was performed i n d u p l i c a t e . In a d d i t i o n t h r e e glove 
m a t e r i a l s (nos. 2, 3, 5) were t e s t e d i n d o u b l e l a y e r s . 
From gloves n o s . 1, 2, 3, 4, 5 and 7 one u s e d sample was r i n s e d with 
ethanol and d r i e d . With these glove samples t h e a n a l y s e s were repeated once. 
In glove no. 5 experiments were per formed w i t h m a t e r i a l from both f inger and 
w r i s t . For buty l a c r y l a t e the gas Chromatograph a n a l y s i s took p lace with a 
column i d e n t i c a l t o the one for methyl m e t h a c r y l a t e b u t with t h e following 
isotherm programme temperatures: i n f e c t i o n p o r t 69 e C, oven 70oC, d e t e c t o r 230oC. 
For the a n a l y s i s of acrylamide t h e g l a s s column c o n t a i n e d 5% s i l i c o n e OV 
101 on gaschrom Q and the isotherm programme t e m p e r a t u r e s were: i n j e c t i o n 
p o r t 90oC, oven 90oC and detector 2 4 0 o C . 
Both butyl a c r y l a t e and acrylamide were t e s t e d i n t h e s o l v e n t methanol. 
Here n-pentanol served as an i n t e r n a l s t a n d a r d , whi le o c t a n o l - 2 was added t o 
prevent t a i l i n g of the butyl a c r y l a t e o r a c r y l a m i d e p e a k . Standard s o l u t i o n s 
of butyl a c r y l a t e and of acrylamide i n m e t h a n o l c o n t a i n i n g 20.4 mM n-pentanol 
and 7.7 mM octanol-2 were prepared. For t h e b u t y l a c r y l a t e s o l u t i o n s t h e e r r o r 
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was never above 2% i n t h e r a n g e of 5-600 mM. The c a l i b r a t i o n curve d i f fe red 
s l i g h t l y from l i n e a r m t h e c o n c e n t r a t i o n range above 400 mM. As for a c r y l -
amide, t h i s could n o t be d e t e c t e d below a concentrat ion of 60 mM. Between 
60 and 75 mM the e r r o r was 6.5%, from 75 t o 700 mM the e r r o r was 3%. The 
c a l i b r a t i o n curve was l i n e a r . 
The analyses of b u t y l a c r y l a t e and acrylamide were performed once. One 
compartment of t h e d i f f u s i o n chamber was f i l l e d with t h e blank s o l u t i o n : 
methanol, c o n t a i n i n g 20.4 mM n - p e n t a n o l and 7.7 mM o c t a n o l - 2 . The other 
chamber was f i l l e d wi th 3.1 M (40% w/v) butyl a c r y l a t e re spect ive ly 4.2 M 
(30% w/v) acrylamide i n m e t h a n o l c o n t a i n i n g the same a d d i t i o n s . For b u t y l 
a c r y l a t e samples were t a k e n e v e r y 10 minutes, while for acrylamide t h e 
i n t e r v a l s a t which samples were t a k e n varied from 6 t o 30 h r s . 
densbty and thickness 
At the sampling s i t e a s q u a r e a r e a (23x23 mm) was stamped and cut out from 
each g l o v e . The m a t e r i a l was weighed, and the dens i ty determined with a 
pycnometer. From t h e d a t a o b t a i n e d t h e mean th ickness of the mater ia l was 
c a l c u l a t e d . The e r r o r m t h e l a t t e r was 3%. 
water permeability 
We adapted our s t a n d a r d measurements of the water vapour loss from the 
skin (150) t o e s t i m a t e t h e w a t e r permeabi l i ty of some of the m a t e r i a l s before 
and a f t e r exposure t o methyl m e t h a c r y l a t e in the d i f fus ion chamber. A measuring 
cup (area 1.Θ75 cm) was p r e s s e d a g a i n s t the underside of the glove membrane. 
I t was per fused wi th dry n i t r o g e n a s a c a r r i e r t o take the p e n e t r a t i n g water 
vapour t o a modif ied Meeco m o i s t u r e analyser. On top of the membrane an open 
g l a s s c y l i n d e r was p r e s s e d , c o n t a i n i n g a 1.5 cm l a y e r of water. The d a t a were 
recorded a f t e r e q u i l i b r i u m was a t t a i n e d . 
4 . 3 . RESULTS 
Undiluted methyl m e t h a c r y l a t e dissolved the glove sample made of poly­
s t y r e n e - b u t a d i e n e , w h i l e a l l s i x l a t e x glove samples and the polychloro-
butadiene sample showed e x p a n s i o n in the l i q u i d , which reversed a f t e r removal 
from t h e methyl m e t h a c r y l a t e . Yellow coloured m a t e r i a l was re leased i n t o the 
l i q u i d methyl m e t h a c r y l a t e from a l l l a t e x and polychlorobutadiene glove 
samples. After d r y i n g , non-dyed samples were v i s i b l y bleached. Except for 
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Seamless Brown Milled Regular, the remaining five latex samples showed a loss 
of stickiness. The two vinyl glove samples firstly appeared to swell in the 
undiluted methyl methacrylate, but after 1 hr in the liquid they had shrunk. 
Obviously, material of these samples was left in the liquid, since the methyl 
methacrylate liquid foamed afterwards. Material from the polyethylene glove 
did not show any visible change; nor did the liquid in which it was soaked. 
The diffusion of the 4.7 M solution methyl methacrylate appeared to be a 
linear function of time for all glove materials except vinyl. In the latter 
samples (nos. 9 and 10) a first rapid diffusion slowed down to 25% of its 
original rate after 90 min of exposure. After treatment with 4.7 M methyl 
methacrylate in ethanol, this material also appeared shrunken and harder at 
the end of the experiments. Values for diffusion rates were obtained from 
the straight lines or, for vinyl, from the first points of measurement. 
Extrapolation of the lines obtained to zero concentration showed time lags 
(Table 1), (Figure 1). Reproducibility of the results was good; deviations 
in duplicate experiments were less than 3%. Permeability at 350C was sub-
stantially higher than that at 21"C; this difference was larger in synthetic 
polymers. Little permeability difference appeared in the various latex 
samples (Figure 1). 
Figure 1 ; Permeability of surgeons' 
glove material (Seamless Brown Milled 
Regular) to methyl methacrylate in a 
diffusion chamber. Concentration in 
acceptor compartment is shown as a 
function of time. Start concentration 
in donor compartment was 4.7 M ethanol. 
.1-1 J ¥ 
1/ A — A 21eC 
'•^ 1 1 1 
20 40 60 m m 
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σι TABLE 1: Permeability of glove materials to 4.7 M methyl methacrylate (50% w/v) in ethanol. 
Name and constitution of Density Thickness 210C 350C 
glove material such as g-cm 
designated by the manufacturer 
-3 Time lag шюі-min -cm- Time lag umol-min-1-cm 2 
1. Perry X-Am Tex* 0.939 0.125 2 
latex 
2. Seamless Sensi Grip White* 0.908 0.175 3.5 
latex 12 
double layer 
3. Seamless Sensi Grip Brown* 0.923 0.178 3.5 
latex, brown 
double layer 
4. Seamless Brown Milled Regular* 0.935 0.157 3 
latex, brown 
5. Travenol Triflex* 0.938 0.175 
latex 
double layer 
6. Elastyren* 0.952 0.156 
polystyrene-butadiene 
7. Pioneer Rollpruf* 1.26 0.145 
polychlorobutadiene, green 
8. Gyno-DaXtarin Dispos-a-glove 0.935 0.026 
polyethylene copolymer 
9. Parke-Davis Ready-Wrap 1.16 0.111 <1 
vinyl, blue 
3.5 
1.5 
1.75 
6.7 
4.9 
2.23 
4.7 
4.9 
4.7 
8.2 
5.1 
1.74 
12.2 
1.5 
1.5 
1.5 
6 
2.5 
2 
6.5 
11.3 
7.9 
7.6 
4.4 
7.3 
7.3 
3.4 
18.3 
9.5 
6.1 
not determined 
TABLE 1 (continued) 
Name and constitution of Density Thickness 210C 350C 
glove material such as g-cm- mm Time lag pmol-min- -cm- Time lag umol-min- -cm' 
designated by the manufacturer min min 
10. Tru-Touch 1.17 0.155 1.5 10.1 not determined 
vinyl 
11. Marigold household not determined 4.5 3.5 not determined 
latex, red 
•Sterilized surgeons' glove. 
The household g love (no. 11) had a rough surface , and measurement of i t s 
t h i c k n e s s would t h e r e f o r e not have been meaningful. Although t h i s glove was 
made of c o n s i d e r a b l y t h i c k e r l a tex than the surgeons ' gloves, i t s permeabi-
l i t y t o methyl m e t h a c r y l a t e was not much lower. The polystyrene-butadiene 
glove was r u p t u r e d dur ing experiments in three out of four samples. In one 
exper iment , performed with a sample from a f inger of Travenol T n f l e x , an 
i nc r ea se in t h i c k n e s s by 15% and a decrease in the diffusion r a t e by 25% 
appeared, a s compared wi th the sample from the w r i s t . 
Although r e p e t i t i o n of the diffusion experiments with the same glove 
samples gave e x a c t l y t h e same r e s u l t s , much more s e n s i t i v e measurements of 
the water p e r m e a b i l i t y of the gloves usual ly revealed a decrease a f t e r 
exposure t o methyl me thac ry la t e in ethanol , except in two brands (Table 2) : 
Seamless S e n s i Gr ip White and Travenol T n f l e x . 
TABLE 2: P e r m e a b i l i t y of surgeon ' s glove ma te r i a l s to water, before and 
a f t e r exposure t o 4.7 M methyl methacrylate in e thanol , in 
pg-min - -cm - . 
Glove m a t e r i a l Not exposed exposed 
1. Perry X-Am Tex 
l a t e x 
2. Seamless S e n s i Gr ip White 
l a t e x 
3 . Seamless S e n s i Gr ip Brown 
l a t e x 
4 . Seamless Brown Mi l l ed Regular 
l a t e x 
5 . Travenol T n f l e x 
l a t e x 
6 . E l a s t y r e n 
p o l y s t y r e n e - b u t a d i e n e 
7. Pioneer R o l l p r u f 
p o l y c h l o r o b u t a d i e n e 
3 .6 
1.7 
1.8 
2.0 
1.9 
3.2 
0.8 
3.0 
1.8 
1.2 
1.1 
1.9 
not 
determined 
0.6 
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The diffusion of butyl acrylate appeared to be linear for the 2 latex 
glove materials. For the polystyrenebutadiene and the 2 vinyl gloves the 
diffusion decreased in time. To estimate the diffusion rate in the latter 
3 gloves, the first points of measurement were used. Results are shown m 
Table 3. 
TABLE 3 : Diffusion rates of solutions of butyl acrylate and acrylamide in 
methanol through 5 surgical glove materials, as compared with the 
diffusion rates of a solution of methyl methacrylate in ethanol. 
Nr. Glove material Diffusion rate* ( то1-тіп~1*ст- ) 
Methyl methacrylate butyl acrylate acrylamide 
1. Perry X-Am Tex 6.7 3.9 0.10 
latex 
2. Travenol Tnflex 4.7 2.3 ** 
latex 
6. Elastyren B.2 7.0 ** 
polystyrene-butadiene 
9. Parke-Davis Ready-Wrap 12.2 11.1 0.37 
vinyl 
10. Tru-Touch 10.1 7.4 ** 
vinyl 
* Diffusion rate standardized for a concentration of 4.7 M in the donor 
compartment, assuming Pick's law of diffusion. 
**Below limit of detection (0.08 umol»min-1'cm- ) 
No diffusion of acrylamide through Travenol Tnflex, Elastyren and Tru-
touch gloves could be detected after 30 hrs. Acrylamide appeared to permeate 
through the latex Perry X-Am Tex glove and the Parke-Davis glove. The 
diffusion rate of acrylamide through these 2 gloves was estimated by assuming 
a linear relationship in the diffusion versus time between 0 and 30 hrs after 
the start of the experiments. The results are summarized in Table 3. 
4.4. DISCUSSION 
In our diffusion experiments with methyl methacrylate, aimed at quantitative 
comparison of glove materials, a 4.7 M solution of methyl methacrylate in 
ethanol had to be used to minimize expansion of the membranes and extraction 
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of the auxiliary substances, which would have interfered with the analyses. 
Therefore we were not able to use the same conditions as encountered in the 
operating theatre, where a solution of poly(methyl methacrylate) in methyl 
methacrylate is employed. The concentration of methyl methacrylate monomer 
is declining in the course of the polymerization. This also means that the 
extrapolation of our results to the clinical situation is attended by 
uncertainties. However, we saw no way to bypass this problem. 
While handling the so-called monomer-polymer adhesive mixture, the ortho­
paedic surgeon wears on top of his rubber gloves a pair of cotton gloves 
and on top of these another pair of rubber gloves. After insertion of the 
endoprosthesis, he removes the top rubber and cotton gloves and then continues 
operating the patient wearing the remaining gloves. The exact composition of 
the adhesive mixture is still unknown, but the greater part of the acrylic 
monomer it supposedly contains is still methyl methacrylate. In addition, 
there must be (96): a solvent, a starter (an amine or cobalt salt), 
a radical donor (benzoyl peroxide), and possibly an antibiotic. Benzoyl 
peroxide and hydroquinone are also known contact sensitizers (81, 155). 
The time needed for insertion of the prosthesis is generally much longer 
than the time lag we found in our experiments, which is related to the time 
the methyl methacrylate needs to permeate the glove material. After removal 
of the outer gloves a considerable amount of monomer is left on and in the 
inner glove, as illustrated by our experiments with double layers. Taking 
into consideration the skin temperature of the surgeon, the measurements at 
350C are a better approximation of the real working circumstances than those 
at г^с. 
In contact with the cement, low molecular-weight ingredients of the gloves 
dissolve in the monomer, especially from expanded parts. Among those are 
oligomers and auxiliary substances such as rubber additives. 
In the manufacturing process the glove, after being formed, stays on the 
mould with the fingers in downward direction. The final flow of the very 
viscous material results in thicker latex m the fingers than in the wrist, in 
accordance with our observation, but also results m thinner parts in the 
webs between the fingers. When the gloves are worn the contact is occlusive, 
which stimulates sensitization (85). Some materials showed a decrease in 
water permeability after exposure to methyl methacrylate. This means that the 
degree of occlusion increases after contact with the monomer. 
Elastyren gloves were developed especially for surgeons who are contact-
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allergie to most of the commonly used rubber additives. These gloves contain 
only one additive, which has a very low allergenic potential (67). In con-
tact with methyl methacrylate, dissolution of this glove occurred in a short 
time. Pioneer Rollpruf is labelled "for those allergic to natural rubber" by 
the manufacturer. Natural rubber, however, does not induce sensitization 
(29). Probably the manufacturer of Pioneer means by this statement that these 
polychlorobutadiene gloves contain lesser amounts of accelerators and anti-
oxidants than gloves made from natural rubber (53) . 
Considering the results of our investigation, there is no doubt that, 
when using these gloves, the surgeon is exposed to methacrylate under occlusion, 
but probably also to other contact-sensitizing chemicals such as benzoyl per-
oxide, hydroquinone, cobalt compounds, rubber additives, antibiotics, etc. 
Vinyl appeared to be an inferior material, with the highest initial per-
meability and releasing plasticizer in the monomer. Polyethylene copolymer, 
although very thin, gave the best protection from methyl methacrylate diffusion. 
This material, however, is not sufficiently elastic, and is easily perforated 
by a sharp edge or a rough surface. 
We must conclude that, during cementing of prostheses, protection is very 
unsatisfactory. Modern plastic technology should be able to produce a material 
that has the characteristics of polyethylene copolymer in the diffusion of 
methacrylate, but is thicker, mechanically stronger and somewhat more elastic, 
and does not contain sensitizing agents. 
We tried to contact manufacturers of these materials but, even when the 
concern of occupational physicians in industries where similar problems exist 
and of dentists is added to ours, large scale demands are improbable, and 
production is consequently not very interesting today. Therefore other pre-
ventive measures should be developed to avoid contact with methyl methacrylate 
monomer while cementing endoprostheses. Fregert (56) recommended the 
following: 
- packages of the liquid and powder should be of a disposable type 
- mixing procedure should take place in a fume hood 
- mixing should be done with utensils, without glove contact, until the 
material is no longer sticky 
- the surgeon and other personnel with contact should use at least 2 layers 
and preferably 3 layers of gloves during handling of the cement, and 
then immediately remove all gloves 
- utensils used for mixing, remnants of bone cement and gloves should be 
destroyed. 
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However, in the long run the development of a glove impermeable to methyl 
methacrylate and other acrylates will be necessary. 
The results with the butyl acrylate and acrylamide experiments should be 
interpreted more qualitatively rather than quantitatively, because of the 
limited number of measurements and the use of different solvents. The ob-
served differences m permeation rates of methyl methacrylate, butyl acrylate 
and acrylamide cannot apparently be explained by parameters like molecular 
weight, chemical reactivity or lipophilicity. 
It does serve as an illustration for the need to test a glove for per-
meability to every substance, with which it comes into contact. It cannot be 
assumed on mere theoretical grounds that a glove will offer sufficient pro-
tection against a certain substance. 
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C H A P T E R 5 
KINETICS OF METHYL ACRYLATE AND METHYL METHACRYLATE AFTER 
INTRAVENOUS AND EPICUTANEOUS ADMINISTRATION IN THE GUINEA PIG 
5.1. INTRODUCTION 
Investigations on the metabolism of 1''C-methyl methacrylate in rats (21, 
34) show an excretion of ^CO- up to 88% of a single dose after oral or 
intravenous administration. As for methyl acrylate, the binding to sulfhydryl 
groups appears to be a major detoxication pathway in addition to oxidation 
to C0 2 (137) . 
Despite the fact that under occupational circumstances skin exposure is 
likely to occur frequently, no quantitative data are available with respect 
to the percutaneous absorption of these compounds. Methyl methacrylate is 
known to penetrate through rubber gloves (122, 169), and may give rise to 
serious side effects in humans (49). 
Therefore, one of the main goals of the experiments presented here is to 
quantify the transport process of acrylate molecules through the skin of 
guinea pigs. The characteristics of this process can be analyzed from 
acrylate concentration measurements after the epicutaneous dose. Classically, 
based on a 2 or more compartment model, the concentration vs time functions 
can then be fitted to a set of exponential functions (105). In contrast to 
this approach we used a model based on mathematical systems theory (98, 161) 
to calculate the acrylate transport process through the skin vs time. With 
the aid of deconvolution methods (25), we can calculate the absorption input 
function (AIF). This is to be interpreted as the number, or fraction of 
acrylate molecules entering the central bloodpool per time vs time. Informa­
tion such as the total fraction transported, i.e. bioavailability, and the 
mean absorption time (MAT) can then be derived from this input function. 
With the aid of this method it is possible to study the role of the skin as 
a barrier in the kinetics of methyl methacrylate and methyl acrylate. 
5.2. MATERIALS AND METHODS 
ahemiaals 
Methyl (2,3-:l'tC) acrylate, specific activity 0.73 mci-mmol-1 and methyl 
(2- С) methacrylate, specific activity 0.347 mCi-mmol-1, were obtained from 
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the Amersham Radiochemical Centre, England. (2,3- C) acrylic acid was pre­
pared by hydrolysis of methyl (2,3-1',C) acrylate in 0.15 M NaOH, followed by 
neutralization with concentrated HCl. The NaH 1 t o , was prepared by bubbling 
1
'
,C02 through a 0.15 M NaOH solution. 
Analytical grade ethanolamine and 2-propanol were from Merck (FRG) and 
hexanol, tnethylamine and dodecanethiol came from Aldrich (Belgium). 
Soluene-350 and Instagel were obtained from Packard (The Netherlands). 
animals 
Female Dunkin Hartley guinea pigs, 5-7 months old, weighing 550-750 g were 
obtained from the Broekman Institute (The Netherlands). Under anesthesia poly­
ethylene catheters (inner diameter 0.5Θ mm, outer diameter 0.96 mm) were placed 
into the femoral artery and the jugular vein and led subcutaneously to the 
nuchal area where they went out of the body. The guinea pig was used for the 
experiment after recovery from this operation, which was assumed when her 
weight was at the pre-operation level. 
expertmental design 
During the experiments the animals were housed in all glass metabolism 
cages, designed to trap expired air and to separate urine from faeces. Food 
(Hope Farms, The Netherlands) and water were provided ad libitum. Air was 
drawn through the cage (volume 24 1) at a rate of 400 ml«min- by means of a 
Verder Uni V-200 peristaltic pump, so the pressure inside the cage was some­
what lower than outside. This air was led through a train of gas-washing bot­
tles: the first one was empty and put on ice to trap expired water; the next 
two bottles contained 5% (v/v) dodecanethiol and 2.5% (v/v) tnethylamine in 
hexanol to trap unmodified acrylate and the last two bottles contained 20% 
water m ethanolamine (v/v) to trap expired COQ. 
Samples from these bottles were taken frequently via syringe-connected 
catheters without interruption of the air-flow. The solutions in the bottles 
were exchanged for fresh ones at least 3 times m 24 hrs. Urine and faeces 
were collected at 24 hrs intervals. The top of the cage was closed by means 
of a tabletennisball, in which holes were drilled in order to let through the 
catheters of the guinea pig. Blood samples were taken by connecting the 
arterial catheter outside the cage with a syringe filled with heparmized 
salme and drawing the piston until the catheter was completely filled with 
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freshly obtained blood. Then the connection was interrupted and by means of 
the heart-pump the arterial blood dripped into a hepannized tube. When the 
required amount (0.1 ml) was collected, the catheter was again connected with 
the syringe and the content of the catheter and 0.1 ml saline was injected 
again into the animal. 
administratton of the compounds 
For the intravenous application the radioactive compound, dissolved in 
4 ml saline, was administered via an infusion of 15 or 30 minutes into the 
jugular vein catheter. The amount remaining in the catheter was washed down 
with 1.0 ml of saline. In these experiments the dose applied to each animal 
was for ME 0.092 mmol, for MMA 0.13 mmol, and for acrylic acid 0.15 mmol. 
For the epicutaneous administration, the left flank of the guinea pig was 
shaved and a glass cup, inner diameter 16 mm, outer diameter 24 mm, height 
10 mm was glued to the shaved skin with cyanoacrylate glue (Amycon's CY 2000, 
medium viscosity, Aldnch, Belgium) 18 hrs before the start of the experi­
ment. The radioactive compound was injected undiluted in the cup, which was 
closed immediately afterwards with a glass-cover with cyanoacrylate glue. 
Applied doses were 0.11 mmol of ME and 0.19 mmol of MMA. Elastic adhesive 
bandage of 7.5 cm width (Tensoplast, Smith and Nephew Ltd., England) was wound 
around the animai in such a way as not to hinder its respiration. 
In order to determine the residence time of CO2 in the guinea pig body 
and in the metabolism cage, 3 additional experiments were carried out in 
which 4 ml of a 0.15 M МаН1ЦСО-, solution was administrated intravenously in 
guinea pigs, not used before. 
At the end of the experiments the animals were killed by an intravenously 
injected overdose of pentobarbital (Narcovet ). 
Preparation for liquid scintbllation counting 
Blood samples were fractionated in plasma and cells by centnfugation 
immediately after collection; they were stored at 40C for less than 12 hrs. 
Of the animals, exposed epicutaneously, the glass cup, when still on the 
animal just killed, was rinsed 3 tunes with methanol, then removed and again 
rinsed, once with methanol and twice with petroleum ether. Rinsing fluids 
were collected in glass-scintillation vials until counting. The remaining 
activity in the cup was determined by heating the cup in a solution of potas­
sium bichromate (5% w/v) in concentrated sulphuric acid and trapping the 
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produced CO2 in ethanolamine. 
The exposed skin was widely excised, cut into small pieces with scissors 
and solubilized in Soluene-350. 
Plasma, urine and washing-bottle samples were analyzed by direct scintilla­
tion counting of weighed samples in Instagel. The ethanolamine samples required 
addition of methanol to obtain clear, homogenous samples. 
The faeces and the killed animals were stored at -20oC until counting. Of 
the exposed animals, lung, liver, kidney, spleen, heart and skin were assayed 
separately, bram and adrenals were also assayed in some animals. The remaining 
carcass and intestinal contents were homogenized. Faeces were also homogenized 
after addition of an equal volume of water. Quadruplicate weighed samples of 
the above-mentioned tissues and excreta were dissolved m 1 ml Soluene-350 
and counted in 15 ml of an Instagel - 0.6 N HCl (9:1 v/v) mixture. 
Erythrocytes (0.040 ml) were dissolved m 1 ml of Soluene-3 50 - 2-propanol 
(1:1 v/v), bleached by addition of 0.3 ml HjO- 35% (w/v) and counted in Insta-
gel R - 0.6 N HCl (9:1 v/v). All solutions were counted m a Packard Tn-Carb 
33Θ0 liquid scintillation counter. 
5.3. PHARMACODYNAMICAL ANALYSIS 
The tools used to calculate the acrylate transport process through the 
guinea pig skin have their roots in mathematical systems theory and gain 
popularity in pharmacological research. The line of thought can be explained 
with the aid of Figure 1, where a specific output function C(t) and dose 
input function D(t) can both be monitored as a function of time {e.g. plasma 
curves). The transport process passes molecules from input site to output 
site with a speed <Mt), according to the convolution integral equation (eq.l) . 
Figure 1 : The "black box" notation, which input dosage flow D(t) and transport 
speed iMt); the resulting concentration C(t) is analytically 
determined by the convolution equation. 
D(t)- ψ(1) -•C(t) 
The unknown iji(t) can be derived from this equation, by means of the mathematical 
process called deconvolution. Several deconvolution methods are known from 
literature (35, 36, 162, 163); in the one used in these investigations (25), 
the evaluation of the convolution integral equation is based on Fourier trans­
formations. 
76 
The function of interest, e.g. the acrylate input flow into the central 
bloodpool, resulting from the skin absorption process, is derived from 2 
different experiments (Fig. 2). Firstly, the total body transport function 
(TBTF) for the acrylates is determined <eq. 2), using an intravenous dose: 
the concentration profile is measured from a known input function, e.g. shot 
or infusion (Fig. 2, route a). Secondly, the unknown input function after 
epicutaneous application (Iec(t)) is calculated from the resulting concentra-
tion profile (Fig. 2, route b), and the TBTF derived in the former step. 
Figure 2: The system model used in the crossover study. Applying an intra-
venous dosage flow Dlv(t) results in a concentration profile 
Civtt) (route a), supplying information about the total body 
transport function TBTF(t). Application of an epicutaneous dose 
Dec results m a concentration profile Cec(t) (route b ) , thus 
gaining information about the input dosage flow into the central 
bloodpool I(t), using the TBTF(t). 
C,vtt) 
Cec(t) 
The overall formula is presented by equation 3 and the Area Under Curve (AUG) 
and MAT parameters by equations 4 and 5 respectively. 
Because it is not only the acrylate activity, that is detected in the 
plasma, but also any appearing metabolite activity, the model of Figure 2 
cannot be applied directly to this case. In fact, for all different types of 
metabolites a different TBTF is involved, which receives input either from 
the acrylate TBTF output site or from their precursors output site. 
The new model is a composition of the various TBTF's of which the output 
refers to some C-activity, and all the outputs are to be integrated to one 
pool to be able to describe the total plasma-1''c measurements (Fig. 3a) . 
However, a combination of subsystems can be reduced to a single system which 
has the properties of all these subsystems (25). As can be seen from Figure 
3a, the model can then be reduced to the configuration of Figure 2, whereby 
the TBTF is the function which describes the transport of C-acrylate from 
the input reference point to 1''c-activity at the output reference point. 
So far for the plasma measurements; m case of the COg measurements some 
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C(t) = concentration output as a function of time. 
D(t) = dose input as a function of time. 
ψ(ί) = transport as a function of time. 
V = cardiac output. 
В 
С. (ω) = Fourier transformed concentration output function after intravenous 
dose. 
I = input function after epicutaneous dose. 
AUCT = area under curve of 1^  
I
ec
 e c 
MATT = mean absorption time of !__. 
ec
 e c 
^ . С О ^
 = С
і
 ( Ш )
'
 0 f C 02· 
Civ ρ 1 ( ω ) = Сі ( ш ) ' o f P l a s m a· 
F. = component (molecule or group of molecules) with a Fourier transformed 
transport function F.(ω). 
E. = extraction factor of component F.. 
E . = extraction factor of component F., which is transformed to CO.. 
f. = original acrylate fraction available from the skin absorption. 
f. = fraction of original acrylate which does not bind to plasma. 
f- = fraction of original acrylate which binds to plasma. 
f. = metabolite fraction, formed in the skin 
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F (ω) = Fourier transformed transport function of the skin. 
MAT = mean absorption time of the skin. 
MRT = mean residence time. 
Θ1 
Figure За: System model applying to plasma measurements. 
Figure 3b; System model for CO, measurement 
Ψ aery late metabolism 
ФсОг -*• cage - flow -*"Cco 
extra subprocesses are involved too, like the metabolization step from acrylate 
to ultimately C0_, the COn expiration process, and finally the flow through 
the cage. The latter is considered to be a first order process. All these 
processes are sequential and, as it is, again the samples are not taken from 
the well-defined output reference site. Therefore, the model as depicted in 
Figure 2 has to be extended with those 3 subprocesses to be able to describe 
the output reference point in terms of CO, measurements (Fig. 3b). But because 
of the same reason that has just been mentioned for the plasma measurements, 
those subprocesses can be thought of as being part of the central subsystem, 
so the TBTF now stands for the transport of 1цС-асгу1аіе from input reference 
to ''CO, at the cage output. As the flow through the cage is known, this 
subprocess will be eliminated from the CO, measurements using deconvolution, 
so the actual output reference will now be the expiration output site, and 
the model of Figure 3b also reduces to the one depicted in Figure 2. 
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5.4. RESULTS 
5.4.1. General 
For both acrylate esters and both ways of administration the excretion pat­
terns are shown in Table 1, together with the results of the experiments with 
acrylic acid. As for faeces, in all experiments less than 1% of the dose was 
excreted га this pathway. The total amount of radioactivity which remained 
TABLE 1: Excretion of radioactivity in guinea pigs after administration of 
methyl (^C) acrylate (ME), methyl (11,C)methacrylate (MMA) and 
("θacrylic acid (AA) . 
istance 
ME 
ME 
ME 
ME 
ME 
ME 
ME 
MMA 
MMA 
MMA 
MMA 
MMA 
MMA 
MMA 
AA 
AA 
Administration 
route 
intravenous3 
intravenous3 
intravenous13 
epicutaneous 
epicutaneous 
epicutaneous 
epicutaneous 
intravenous3 
intravenous3 
intravenous 
epicutaneous 
epicutaneous 
epicutaneous 
epicutaneous 
intravenous3 
intravenous3 
Urine 
(% of dose) 
47.θ 
48.2 
46.5 
32.6 
41.8 
31.6 
40.3 
9.7 
10.1 
11.3 
18.9 
15.9 
14.5 
19.5 
5.0 
5.1 
1 Ч
С 0 2 
(% of dose 
36.5 
36.3 
36.7 
39.8 
36.9 
46.0 
38.7 
69.7 
68.9 
66.5 
49.2 
55.4 
56.8 
57.6 
80 
78 
Exp . time 
(hours) 
24 
24 
28 
28 
29 
39 
52 
24 
28 
24 
32 
60 
60 
60 
24 
24 
30 minutes and 15 minutes infusion. 
in the body after termination of the experiment was measured in 10 animals 
and varied between 12% and 22% for both ME and MMA. Total recovery (mean+s.d.) 
was 93.5±2.3% (n = 6) for the epicutaneous experiments and 98.0±1.0% (n = 4) 
for the intravenous experiments without significant differences between the 
2 tested acrylates. 
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Table 2 presents the data of the organ counts. In order to correct for 
differences in exposure time and dosage, the results are presented as relative 
to the activity (dprn-mg- ) of the homogenized carcass. Brains and adrenals 
which only were counted in 2 animals dosed with MMA, did not show a higher 
activity than other internal organs. Upon intravenous administration 1.5±0.2% 
of MMA and 2.3±0.2% of ME was excreted unmodified. With the epicutaneous 
experiments it was impossible to distinguish between leakage from the cup 
and excretion from the animal. 
TABLE 2: Range of radioactivity of organs relative to the activity of the 
carcass after epicutaneous (ec) and intravenous (iv) administration. 
Organ Methylmethacrylate Methylacrylate 
ec (n = 3) iv (n = 2) ec (n = 3) iv (n = 2) 
Carcass 
Skin 
Liver 
Lung 
Spleen 
Kidney 
Heart 
1.0 
1.0-1.1 
2.6-4.1 
1.8-2.2 
2.2-3.1 
3.0-3.4 
1.2-1.3 
1.0 
1.1-1.1 
2.3-2.3 
2.3-2.6 
2.7-4.2 
2.6-2.7 
1.2-1.2 
1.0 
0.6-0.6 
3.4-3.7 
3.2-3.5 
2.7-5.4 
3.8-4.4 
1.8-2.4 
1.0 
0.5-0.6 
3.9-4.1 
3.7-4.7 
2.9-4.1 
4.0-4.6 
2.8-2.8 
Since inhalation subsequent to leakage from the cup could interfere with 
the measured absorption, we only used the data from the epicutaneous 
experiments in which less than 5% was excreted as unmodified acrylate. The 
part of the dose remaining in and on the exposed skin was considered not to 
have entered the animal and thus not included m the given dose. Table 3 
shows which part of the total dose remained in the skin and on the skin. 
The exposed skin of the animals dosed epicutaneously with ME always showed 
gross signs of inflammation (edema, reddening of the skin), while the 
animals treated with MMA did not show a visible change in the skin. 
A significant amount of radioactivity was retained m the blood cells 
upon administration of ME. This cell-bound radioactivity did not decline 
up to 10 days after dosage. With intravenous administration the activity in 
the erythrocytes only rose during the infusion and not afterwards, while 
in the epicutaneous experiments a much longer time (10-20 hours) was needed 
to reach the maximum radioactivity. MMA nor acrylic acid gave rise to the 
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TABLE 3: Part of the dose of methyl acrylate (ME) and methyl methacrylate 
(MMA) that did not enter the systematic circulation in the epicutaneous 
experiments. 
istance 
ME 
ME 
ME 
ME 
MMA 
MMA 
MMA 
MMA 
Skin 
(% of dose) 
12.3 
9.1 
25.θ 
8.2 
11.2 
6.3 
4.2 
8.1 
Exp. time 
(hours) 
28 
29 
39 
52 
32 
60 
60 
60 
retaining of activity in the blood cells. Because of the apparent irreversibi­
lity of the binding of ME to blood cells we could concare the total amount 
of С activity of these cells between intravenous and epicutaneous administra­
tion after correction for the total dose given. In this way we could determine 
the percentage of ME in the epicutaneous experiment, which reached the blood­
stream in such a chemical form that it could bind to blood cells apparently 
irreversibly. For the intravenous experiments we found 5.6±0.3% of the dose 
in the blood cells (n = 3), for the epicutaneous experiments (n = 4) 4.2±0.4%, 
so it appeared that 75±11% of the dose passed the skin barrier unmodified. 
5.4.2. Pharmacokinetic results 
Primarily results will be summarized considering both C0 2 and plasma measure­
ments (Table 4), because their discrepancy is responsible for the conclusions 
that have been drawn. Thereafter the calculated absorption input functions 
(AIF) are considered for CO- and plasma measurements (COj-AIF resp. PL-AIF) 
per acrylate type; the AIF's are truncated at that end-time which is the same 
as in the corresponding epicutaneous experiments. As total 1I*C activities are 
determined, no differentiation can be made between the acrylate and any appearing 
metabolites m the plasma. 
The CO_ measurements of the bicarbonate experiments show a mean mean-transporta-
tion-time (MTT) for l l tC0 2 of 67±2 m m ; the MTT through the cage is calculated 
to be 60±5 m m , resulting in 7±5 min for the 1',C09 elimination from the guinea 
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TABLE 4: Area under curve (AUG) and mean absorption time (MAT) parameters 
calculated from the CO2 and plasma absorption input function (AIF), 
truncated (t)/extrapolated (°°) , for methyl acrylate (ME) and methyl 
methacrylate (MMA). Also denoted is the time of the peak absorption 
of the corresponding AIF's.tmax. 
Substance 
ME 
ME 
ME 
ME 
MMA 
MMA 
MÍA 
MMA 
CO2-
AUCJ./AUCC 
1.12/1.19 
0.97/1.15 
1.27/1.42 
0.88/1.08 
0.64/0.66 
0.56/0.77 
0.74/0.79 
0.78/0.87 
-AIF 
MATt/MAT00 
(minutes) 
574/671 
389/658 
840/1096 
730/1122 
761/787 
906/1432 
1204/1427 
1231/1615 
Plasma 
AUCt/AUC„ 
0.89/0.96 
0.83/0.93 
a 
0.79/0.80 
a 
0.65/0.76 
a 
0.92/0.92 
-AIF Чах 
МАТ,./МАТ
Ш 
(minutes) 
628/742 
510/774 
a 
1303/1308 
a 
854/1147 
a 
902/902 
C02/PL-AIF 
(minutes) 
270/210 
200/ 30 
350/ a 
430/130 
440/ a 
570/910 
480/ a 
610/940 
a: Could not be determined because of too little samples in the epicutaneous 
experiment. 
pig. In fact the mean-transportation-tune of CO2 from the input is reference 
point to the expiration output-site. 
Because of the homogenity of the group concerning the intravenous results 
(Table 1), the results are averaged for both the plasma and CCK measurements. 
Before averaging, all the i.v. concentration time functions were normalized 
to a unit-bolus input function, hereby making use of deconvolution with the 
infusion input function. Analogous, from all 1',CO„ measurements the cage-
flow is eliminated by deconvolution of the original measurements with this 
first order process. 
Both methyl acrylate (ME) and methyl methacrylate (MMA) intravenous 
experiments show the same difference between the CO, and plasma curves: the 
tail part of the latter decreases much more slowly compared with the former 
(Fig. 4). ME and MMA epicutaneous experimental results show the same phenomenon 
as the intravenous results do: the plasma llfC activity decreases much more 
slowly compared with the CO, measurements (Fig. 5). 
Focussing upon the AIF's for ME (Fig. 6) which are calculated according 
to the model presented in Fig. 2, the corresponding AUC's of the COj-AIF's 
vary from 0.88 to 1.27 (4 measurements), derived from the truncated AIF. The 
AUC's of the PL-AIF's are calculated from three experiments: 0.79 to 0.89. 
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The mean plasma and corresponding CO2 total body transport functions 
determined after intravenous application of a) methyl acrylate (ME) 
and b) methyl methacrylate (MMA). These functions are the result of 
deconvoluting the concentration profiles with the infusion input 
function, thereafter the functions are normalized so that the area 
under curve (AUC) equals 1. The function values are expressed as 
the fraction of the total dose that is eliminated from the central 
bloodpool; the time axis is given in hours. 
% /MINUTE 
1000 
0 100-
0010 
0 001 
1000-
0 100-
0010-
r-iOOOl 
0 8 16 2L 32 ¿,0 0 8 16 2U 32 40 
HOURS 
An example of the plasma and corresponding CO2- С activity in 2 
guinea pigs determined after epicutaneous application of a) methyl 
acrylate (ME) and b) methyl methacrylate (MMA). For the plasma 
data the dimension is DPM/50 yl plasma, and for the CO, data this 
is DPM exhaled per second. 
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Figure 6: The absorption input functions (AIF) for methyl acrylate (ME) in 
2 guinea pigs, calculated on basis of the CO, and plasma measure-
ments. Note the remarkable difference between the 2 AIF's for each 
guinea pig. The function values are given as the fraction of the 
total dose applied epicutaneously that enters the central blood-
pool. The time axis is given in hours. 
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Figure 7: The absorption input functions (AIF) for methyl methacrylate (MMA) 
in 2 guinea pigs, calculated on basis of the COo and plasma measure-
ments. Note the remarkable difference between the 2 AIF's for each 
guinea pig. The function values are given as the fraction of the 
total dose applied epicutaneously that enters the central blood-
pool. The time axis is given in hours. 
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After mono-exponential extrapolation the AUC's are resp. 1.08-1.42 and 
0.80-0.96, the former resulting in a bioavailability of more than 100%. The 
MAT varies from 389-840 min (CO.-AIF) and 510-1303 min (PL-AIF), after extra­
polation resp. 658-1122 m m and 742-1308 m m . 
In the case of MMA (Fig. 7), the AUC's of the CO -AIF's and PL-AIF's are 
0.56-0.78 (n = 4) and 0.65-0.92 (n = 2) respectively; after extrapolating 
0.66-0.87 and 0.76-0.92. The corresponding MAT's vary from 761-1231 m m 
(CO2-AIF) and 854-902 m m (PL-AIF) and after extrapolation resp. 787-1615 
m m and 902-1147 m m . 
5.5. DISCUSSION 
At the moment there is no "animal of choice" to study percutaneous absorption 
(22, 170). We chose the guinea pig for reasons of economy, easy handling, 
available experience on canulation of blood vessels and evidence that it is 
a reasonable animal model for this purpose (5). 
The results of the intravenous administration of MMA to the guinea pig 
•i.e. the rapid biotransformation to ССЬ are in good agreement with the results 
of Bratt and Hathway (21) and Crout et al. (34), who applied MMA to rats. 
Together with other experiments in vivo (39) and in vitro (43), the available 
results may suggest a rather low potency of MMA to yield reactive metabolites. 
The excretion pattern of ME, with much more activity in the urine (Table 1), 
is markedly different from the one of MMA. There is also a considerable 
production of thioethers in the urine after administration of ME (137), as 
a consequence of the direct Michael addition of ME to glutathione (39). 
Another indication for the nucleophilic character of ME is the apparently 
irreversible binding of ME to erythrocytes, a phenomenon which is also en­
countered with acrylonitnle (1) and acrylamide (106). In spite of this 
alkylating potency of ME compared to MMA, we found no difference in the 
percentage of the dose which remained in the body after termination of the 
experiment. 
Hydrolysis appears to be the ma^or detoxification pathway of ME (139). 
Since acrylic acid did not bind to erythrocytes, we could determine the 
upper boundary of the fraction of ME which was hydrolysed in the skin: 25±11%. 
As shown in Figures б and 7 and in Table 4, there is an unexpected dis­
crepancy between the acrylate absorption input functions calculated from the 
CO- data and on the other hand from the plasma data. This leads to the 
conclusion that the transport process of acrylate from quinea pig skin to 
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central bloodpool can not be modelled as it is in Figure 2 (route b) . More­
over, the calculated functions will be an integration of a number of unknown 
processes among which is the acrylate skin transportation process. Although 
the number of experiments is limited especially in the case of MMA, conclusions 
can be drawn. First we will discuss the intravenous experimental outcomes 
(Fig. 4), then the AIF-ME results (Fig. 6) and afterwards the AIF-MMA results 
(Fig. 7) . 
On the basis of the proposed system model (Fig. θ), the conclusions will 
be discussed. At first the component F3 will not be taken into account 
Figure 8: The system model for both methyl acrylate (ME) and methyl methacry-
late (MMA). All boxes represent the transport processes of the 
molecules involved: input site and output site refer to the same 
kind of molecules or group of molecules. Formation of a (group of) 
metabolite(s) is depicted as the input flow into a new transport 
process and originating from the transport process of its precur­
sor (s). Refer to the text for the meaning of the symbols. 
(eqs. 6-10), but the results will show the necessity of its presence. All 
boxes depicted m the system model, represent the transport processes of the 
molecules involved: input site and output site always refer to the same kind 
of molecules or group of molecules. Formation of a (group of) metabolite(s) 
is depicted as the input flow into a new transport process and originating 
from the transport process of its precursor(s). The transport function for 
the acrylate will be called Fl. 
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The difference between the plasma and CO2 intravenous results in both 
acrylate experiments can be explained by assuming an extra component in the 
plasma kinetics, the transport function of which is called F2 in Figure 8. 
This component is additional to the plasma level and may be due to the very 
slow release from a binding site of the acrylate itself: from literature it 
is known that ME and MMA have approximately the same binding constants with 
bovine serum albumin (59). 
The contribution of the ''cc^  activity in the plasma is so small compared 
to all other components, that in all equations 6-10 its contribution has not 
been taken into account. Furthermore, the ССЦ clearance from the body is so 
fast (7±5 m m ) compared to the acrylate clearance (several hours) , that the 
influence of the CO. clearance on the total results will be neglected. 
Referring to Table 4 the bioavailability resulting from the ME CC^-AIF appears 
to be more than 100%. So, a larger amount of CO2 has been formed in the 
epicutaneous experiment relative to the intravenous experiment. As shown in 
Table 1 the total CO- production seems independent of the acrylate infusion 
rate, thus a saturation effect of the metabolizing system is not very likely. 
Then the bioavailability over 100% can be explained by the fact that a meta­
bolite of ME must have been formed m the guinea pig skin (F4). Then from 
equations 9a and 9b and Table 4 it follows that the partial CO, clearance 
of Fl (Е01) will be less than the partial COj clearance of F4 ( E Q 4 ) . 
From equations 8a and 8b it is evident that both AIF's are a sum of two 
different functions. The first function is the transport function of the skin 
itself and the second function is a convolution of this skin transport func­
tion with another complex function, which is composed of Fl, F2 and F4 for 
the AIF π or Fl and F4 for the AIF C 0 . Then the difference in the peak time 
absorption of these AIF's (t„v/ Table 4) can be explained by the contribu­
tion of the very slow transport function in the denuminator of equation 8b 
compared to the one in 8a. These denuminators are directly related with the 
total body transport functions (eqs. 6a and 6b and Fig. 4). 
As F2 is the transport function mainly responsible for the very slow decline 
in the plasma activity, its MRT will then be much larger than any MRT of the 
other components. For this reason it cannot be explained from equations 10a 
and 10b, why the MAT on basis of the plasma measurements is larger than the 
MAT on basis of the CO- measurements. Therefore, an extra component F3 is 
needed, which might result either from biotransformation m the guinea pig 
skin or from other components in the plasma. The one property that F3 must 
91 
have to explain the results, is a large MRT. 
The conclusions from the MMA absorption input function are in essence 
comparable with those concerning the ME absorption input function, although 
derived differently. In all AIF cases (on the basis of the CO^ measurements) 
the bioavailability appears to be substantially less than 100%. So, metabolite 
formation in the skin can then also be the conclusion, which implies an extra 
component F4, analogous to the case of ME. 
The shift in the peak time absorption for the plasma AIF to the right from 
the CO2-AIF (see ^
а х
. Table 4) leads to a contradiction, when the same reason­
ing as in the ME case is applied here. So, the conclusion is that in the MMA 
system model another component F3 must be included too. 
So, for both ME and MMA the equations 6-10 must be expanded with a compo­
nent F3, which because of the uncertainty about its origin, will lead to a 
wide variety of possible system model equations. For reasons of the limited 
number of experiments, it is not possible to extract the one and only correct 
set of equations, and, with those, the proper system model. Then the conclusion 
is that for both acrylates at least one type of metabolite is formed in the 
skin. 
The metabolite formation in the skin prohibited an exact determination of 
the permeation rate of the 2 tested acrylates through the guinea pig skin. 
On the other hand, it illustrates the need to take the metabolizing potential 
of the skin into account, when assessing the toxicological behaviour of a 
substance. 
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C H A P T E R 6 
ASSESSMENT OF TOPICAL TOXICITY OF 5 MONOMETHACRYLATE ESTERS ON HUMAN SKIN 
WITH WATER VAPOUR LOSS AND IMPEDANCE MEASUREMENTS 
6.1. INTRODUCTION 
Irritant contact dermatitis is believed to have a substantially higher 
prevalence than allergic contact dermatitis (74) . This is not reflected in 
the amount of research, devoted to clarification of its pathogenesis. Reports 
on allergic contact dermatitis greatly outnumber those on irritant contact 
dermatitis. So, not surprisingly, there is a far greater agreement on the 
methods for predictive testing on allergenicity, than for tests on irritant 
capacities. The guinea pig is the animal of choice for determining the 
allergenic potential of substances. For the assessment of the irritant 
potential both albino rabbits and guinea pigs are used, without an exclusive 
preference for one of them (103). 
An allergic contact dermatitis m man can be ultimately diagnosed by means 
of patch testing. Patch testing can be executed in the consulting room. It is 
a test with many pitfalls, but if done with care, it results in a straight-
forward answer: yes or no sensitization. A comparable diagnostic test for 
the detection of an irritant contact dermatitis, to be executed in the con-
sulting room, is not available. Reasons for this may become apparent after 
the following explanatory thoughts. 
An acute irritant contact dermatitis is likely to be the result of a 
single overwhelming exposure to a single causative factor. Diagnosis and 
treatment of such a condition is quite simple (94). On the other hand, a chronic 
irritant dermatitis is supposed to arise from a cumulation of a continuously 
changing variety of small causative factors. Each factor leads to a certain 
impairment of the skin function, thereby making the skin more vulnerable 
to an attack by a following causative factor. Diagnosis of this condition 
is difficult and is often made "per exclusionem". This is to say if in an 
eczematous patient "all" contact allergic investigations give negative 
results and reasons to suspect an atopy are absent. 
However, Malten (97) tentatively formulated a number of clinical signs 
and symptoms by which it may be possible in certain uncomplicated cases, to 
recognize chronic irritant contact dermatitis at first sight. In case of such 
a dermatitis, the most important therapeutic measure is lowering the influence 
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of the most harmful causative factors. Therefore we need to know to which 
factors the patient's skin is especially vulnerable. 
With predictive test methods, strong irritants will be readily recognized, 
but it is the detection of mild irritants which poses investigators for the 
greatest problems. Several animal and human test models have been proposed. 
Some investigators have tried to detect the mild irritants by intensifying 
the exposure, e.g. a closed patch procedure during 10 or even 21 days (74, 
100, 123) . Others have tried to enhance the sensitivity by damaging the 
skin before applying the test substance, e.g. by abrasion with hard particles 
(118), or scarification (58). More elegant methods are developed by Thiele 
and Malten (88, 90, 149, 150, 151). By means of measurements of 2 aspects of 
skin function, water vapour loss and impedance, an impairment of the health 
of the skin can be determined. 
Some advantages of both methods are the facts that they result m numerical 
values, that combinations of exposures can be evaluated, that adaptation may 
be studied, that the dosages necessary are more closely related to exposure 
dosages encountered in everyday life, and that the effect of the experimental 
exposures ideally is barely visible clinically. Nevertheless the disadvantages 
are the facts that the instruments are very expensive, and that full investiga-
tion of a substance is time consuming, because a series of exposures on several 
volunteers may be necessary for a full evaluation. 
In addition to the use of these methods to evaluate the irritant potential 
of a substance, these methods can also be valuable in the clinical setting. 
An increased vulnerability of a patient's skin to a factor in the patient's 
environment can be determined by exposure of the patient to a carefully 
chosen concentration of that factor, and measurement of water vapour loss 
and impedance of his skin. On the basis of the data thus obtained the patient 
can be advised. 
We decided to use the water vapour loss and the impedance measurements 
on the human skin as test methods for the acrylic monomers under investiga-
tion. This study was intended to provide further data, leading to a dermatoló-
gica! risk assessment of these substances. 
Previous investigations (158) had taught us that monoacrylates and dimeth-
acrylates were strong sensitizers with guinea pig test methods, while di-
acrylates were severe irritants to the clipped guinea pig skin. In industrial 
workers, exposed to diacrylates, acute irritant effects on the skin are 
described (13), as well as delayed irritant effects (92) on the skin. The 
94 
latter may be regarded as a variation of the acute type. 
Therefore, monoacrylates and dimethacrylates were excluded to avoid the 
risk of sensitizations in volunteers, and since we were primarily interested 
in the occurrence of mild irritant effects, neither the diacrylates were 
tested. So, the only group available for testing was the group of monometh-
acrylates. 
6.2. MATERIALS AND METHODS 
chemicals 
The following methacrylates were used: ethyl, π-butyl, t-butyl, pentyl 
and 2-hydroxyethyl methacrylate. Purity, origin and structure formulas are 
described in Chapter 2.2. Analytical grade methyl ethyl ketone was obtained 
from Aldnch (Belgium). 
water· vapoicr loss measurements 
The water vapour exuded by the skin is trapped in a metal skin cup, 
covering an area of 1.8Θ cm2, and transported by a constant flow of dry 
nitrogen gas to a Meeco electrolytic water analyzer. With thermistors the 
skin temperature at each skin cup is also measured, since the normal water 
vapour loss is dependent on the skin temperature. The measurements of both 
water vapour loss and skin temperature are recorded on a computer (Mmk 11, 
Digital Equipment). As soon as the temperature standardized water vapour loss 
remains constant (±1%) during 4 minutes, the measurement is stopped, and 
the result thus obtained, expressed in pg«cm- -hr" is used. 
impedance measurements 
Four perspex cups, each covering a skin surface area of about 6 cm2 are 
attached with Velcro strips to the volar site of each arm at the marked 
regions, and filled with a 0.015 M NaCl solution. After 60 minutes contact 
between this salt solution and skin (30 minutes in the measurement directly 
after exposure to the test solutions), platinum electrodes are inserted into 
the solution in each cup. An alternating current (25 Hz) is passed between 
all combinations of any 2 skin cups on one arm, and the impedance and phase 
angles are read with a Radiometer impedance meter GB II e (Copenhagen). The 
platinum electrodes consisted of a horizontal platinum plate (1 cm2) with a 
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soldered wire, insulated by a hard PVC tube, passing through a rubber 
stopper, and connected to the impedance meter with insulated wires and plugs. 
The rubber stopper fitted to the perspex cup. From the read impedance and 
phase angles, the skin resistance (kiloOhm) at each site was calculated (151). 
experimental design 
Volunteers are first allowed to come to rest for about half an hour prior 
to the measurements on a day. Six sites are marked on the volar site of both 
arras. The distance between wrist and elbow is divided in 5 equal parts. The 
site nearest to the wrist is marked as site no. 1, while the site in the 
cubital fossa is no. 5. One-fifth of the elbow-wrist distance, proximal from 
the elbow fold site no. 6 is marked. 
The sites 2, 4 and 6 are exposed to the test solutions, site no. 3 is 
always used as an internal control site and remains unexposed to the test 
solutions or to the solvent of the test solutions. So, both arms have 3 test 
sites and 1 control site each. Site no. 1 is not used for physiological 
reasons (too high a variable sweat secretion), site no. 5 is not used for 
practical reasons (elbow flexion). 
Several days before the experimental exposure, water vapour loss and 
impedance measurements were performed daily in all marked regions. The 
water vapour loss measurements always preceded the impedance measurements, 
since the exposure of all sites to a 0.015 M NaCl solution, necessary for 
the latter measurement, would make the water vapour loss measurement un-
reliable. Directly before exposure to the test solutions water vapour loss 
and impedance of the skin were measured. This also means that exposure to the 
test solutions occurred on a hydrated skin. 
We used 3 concentrations of the methacrylates in methyl ethyl ketone: 
2 M, 3 M and 4.5 M. Approximately 3 ml of a solution of the test substance 
was poured into metal skin cups (inner area about 6 cm 3), fixed to the above 
mentioned sites of the skin with Velcro strips. During exposure, the arms 
were frequently moved gently, to avoid concentration changes. Site 2 was 
always exposed to the 2 M solution, site 4 to the 3 M solution and site 6 
to the 4.5 M solution. Duration of exposure of the sites on the right arm 
was twice as long as the exposure on the left arm, e.g. 5 minutes on the 
left arm and 10 minutes on the right arm. Each skin site was exposed only 
one time to the test solution. After exposure the skin sites 2, 4, and 6 
were cleaned by 3 times wiping with tissues soaked in methyl ethyl ketone, 
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followed by rinsing with tap water and gently drying with a soft tissue. 
Water vapour loss measurements were started again one day after the ex­
posure. Impedance measurements were restarted directly after exposure, except 
m the experiments with ethyl methacrylate and in one experiment with я-butyl 
methacrylate (plotted m Figure 1), in which the impedance measurements were 
started again after one day. 
Both parameters were recorded daily for at least 2 weeks, to collect data 
concerning the repair of the skin. Results are expressed as percentage increase 
or decrease to the simultaneously measured control values of site 3: 
value of exposed site-value of control site 
( ) χ 100% 
value of control site 
The percentage thus obtained is compared with the percentages of that site 
before exposure. 
Based on his experience, obtained during over 10 years of experimental 
research with these methods, both with volunteers and with patients. Malten 
(97) tentatively states that a rise in the water vapour loss or a decrease 
in the skin impedance of 50% or more, compared with the pre-exposure values, 
indicates a clinical risk. Analogous to this statement, we do not draw any 
conclusions, when the deviations of the water vapour loss and impedance 
measurements, compared to the pre-exposure values, are less than 50%. 
In Table 1 data are shown on the duration of exposure and the volunteers 
of the experiments performed. 
TABLE 1: Duration of exposure (in minutes) of the volunteers to the meth-
acrylates, 2 M, 3 M and 4.5 M in methyl ethyl ketone. 
Volunteer no. 1 2 3 4 5 
Substance 
ethyl methacrylate 
л-butyl methacrylate 
t-butyl methacrylate 
pentyl methacrylate 
2-hydroxyethyl meth­
acrylate 
97 
5' ,10' 
20',40' 
5' ,10' 20',40' 
20',40' 
5' ,10' ЗО'^О' 
30',60' 
5· ,ιο' го'^о· 
6.3. RESULTS 
In none of the experiments performed (Table 1), deviations of the water 
vapour loss of the exposed skin of 50% or more could be observed. The results 
of the impedance measurements, carried out one or more days after exposure, 
neither showed deviations of 50% or more, conpared with the pre-exposure 
values. As examples, results of one complete experiment with t-butyl meth-
acrylate are given in Table 2a and b, and 2 independent experiments with 
я-butyl methacrylate are plotted in Figures 1 and 2. 
TABLE 2a: Relative deviations in water vapour (%) before and after exposure 
to 2 M, 3 M or 4.5 M t-butyl methacrylate in methyl ethyl ketone. 
Duration of exposure 20 minutes 40 minutes 
Test concentrations 2 M 3 M 4.5M 2 M 3 M 4.5M 
Time before/after exposure 
1 day before exposure 
directly before exposure 
1 day after exposure 
2 days after exposure 
3 days after exposure 
4 days after exposure 
7 days after exposure 
9 days after exposure 
10 days after exposure 
13 days after exposure 
14 days after exposure 
15 days after exposure 
16 days after exposure 
17 days after exposure 
20 days after exposure 
138 
146 
104 
179 
186 
211 
193 
187 
193 
150 
156 
149 
159 
148 
149 
92 
94 
96 
93 
92 
98 
103 
96 
101 
87 
90 
83 
93 
. 81 
87 
97 
98 
92 
94 
92 
136 
128 
104 
105 
102 
99 
87 
90 
81 
89 
102 
103 
126 
119 
123 
117 
115 
114 
109 
99 
98 
97 
103 
93 
98 
94 
90 
99 
103 
101 
93 
105 
110 
109 
105 
107 
106 
114 
114 
112 
74 
77 
89 
92 
94 
56 
99 
95 
97 
97 
104 
97 
101 
98 
94 
98 
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TABLE 2b: Relative deviations in skin impedance (%) before and after exposure 
to 2 M, 3 M or 4.5 M t-butyl methacrylate in methyl ethyl ketone. 
Duration of exposure 20 minutes 40 minutes 
Test concentration 2 M 3 M 4.5M 2 M 3 M 4.5M 
Time before/after exposure 
1 day before exposure 
directly before exposure 
directly after exposure 
1 day after exposure 
2 days after exposure 
3 days after exposure 
4 days after exposure 
7 days after exposure 
9 days after exposure 
10 days after exposure 
13 days after exposure 
14 days after exposure 
15 days after exposure 
16 days after exposure 
17 days after exposure 
20 days after exposure 
106 
80 
42 
58 
49 
62 
42 
55 
75 
96 
85 
90 
81 
82 
93 
82 
125 
122 
53 
123 
114 
111 
113 
97 
101 
104 
104 
HI 
112 
107 
113 
104 
96 
69 
25 
95 
86 
79 
85 
64 
77 
99 
85 
80 
81 
74 
104 
74 
84 
80 
31 
63 
93 
91 
27 
84 
101 
93 
96 
109 
105 
99 
101 
92 
116 
128 
45 
106 
167 
122 
119 
86 
97 
86 
106 
114 
105 
95 
116 
86 
118 
96 
34 
73 
HI 
100 
105 
89 
62 
76 
82 
82 
76 
68 
99 
72 
When the skin sites were exposed to the test solutions for 20 minutes or 
longer, the impedance measurements, performed directly after exposure, showed 
a decrease of 50% or more in some experiments. For all 4 methacrylates tested, 
the relative deviations in impedance directly before and directly after 
exposure of 20 minutes or longer, are shown in Table 3. The observed decrease 
m impedance appeared to be the most pronounced after the longest exposures. 
In none of the experiments performed, visible changes of the exposed skin 
were noted. 
6.4. DISCUSSION 
An impairment of the skin, as seen after contact with an irritant factor, 
might lead to an enhancement of the permeability of the statum corneum for 
water. In addition, damage to the epithelial lining of the sweat gland 
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TABLE 3: Relative deviation in impedance (%) directly before and after exposure to solutions of n-butyl 
methacrylate, t-butyl methacrylate, 2-hydroxyethyl methacrylate and pentyl methacrylate. 
Duration of exposure 
Test concentration 2 И 
before after 
exp exp 
20 minutes 
3 M 
before after 
exp exp 
4.5 M 
before after 
exp exp 
2 M 
before after 
exp exp 
40 minutes 
3 M 
before after 
exp exp 
4.5 M 
before after 
exp exp 
Substances 
rc-butyl methacrylate 
t-butyl methacrylate 
2-hydroxyethylmeth-
acrylate 
97· 57 83 48 
80 42 122 53* 
87 44 96 78 
79 
69 
14 
39* 
25* 
70 
97 
80 
101 
36* 
31* 
41* 
97 
128 
133 
45* 
45* 
55* 
76 
96 
112 
31* 
34* 
50* 
pentyl methacrylate** 86 68 125 62* 126 54* 95 59 
* Decrease of 50% or more compared to the measurement directly before exposure. 
••Results after 30 resp. 60 minutes exposure. 
106 51* 105 45* 
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duct might also result in an increase of the water vapour loss of the skin 
(151). A decrease in impedance of the skin is supposed to be due to a 
greater mobility of small ions such as Na+, CI", H 30 + and 0H~ in the stratum 
corneum. This greater mobility is likely to be the result of changes in the 
protein configuration of the stratum corneum, as might occur after contact 
with an irritant factor. 
The measured values of both parameters exhibit considerable differences 
between individuals. In order to reduce these spontaneous variations, the 
values are expressed as a percentage of a simultaneously measured value of 
a control site on the same arm. Still, also after this correction, the values 
may vary substantially. This is not surprising, since even in guinea pigs of 
the same strain, maintained under identical circumstances, a considerable 
difference in reactivity to irritants exists. This goes even more for human 
volunteers, with a much greater variety in both inner and outer influences 
on the skin, like "genetic make-up", hormonal status, psychological condition, 
possible internal medication, and outside the experimental situation exposure 
to for instance climatological conditions, soaps, cosmetics, fat solvents 
and irradiation. Therefore the normal, Gaussian curve for resistance to a 
certain factor is expected to be flatter in humans than in laboratory animals. 
In one individual man too, the measured values vary in time. In some 
individuals the highest value before exposure to a test substance is twice 
the lowest value before this exposure. Other individuals exhibit less varia-
tion m the measured values. It is in our opinion not allowed to test only 
individuals with such a low spontaneous variation. This would mean a selec-
tion of volunteers, which makes an extrapolation of the results unreliable. 
So, although this means a loss of sensitivity of the methods, we feel that 
only deviations in the measured values, greater than 50% compared to pre-
exposure values, indicate an impairment of the skin of the tested volunteers. 
In addition, we have to keep in mind that with water vapour loss and 
impedance measurements we do not measure direct effects of a substance on 
the skin. In the skin itself, a variety of reactions may occur as a response 
to contact with a substance. Some of these reactions will lead, for instance, 
to a decrease of the permeability of the skin to water; other reactions will 
have the opposite effect. A change in the exposure conditions of a substance 
to the skin may lead to another set of reactions. We only "see" the summation 
of the effects of all these reactions on, for instance, the permeability of 
the skin to water, but we do not see the contribution of all these different 
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reactions, or homoiostatic mechanisms, of the skin. 
A simple dose-effect relationship is not very likely under such circumstances. 
The possibility exists that a higher dose will have less effect on one or both 
parameters, measured by us. 
The observed decrease in impedance of the skin directly after exposure to 
the tested methacrylates during 20 minutes or longer (Table 3), may indicate 
a risk for the health of the skin. This applies to persons, who come into 
contact with these methacrylates under comparable circumstances. This 
conclusion, however, needs to be drawn very cautiously. We cannot exclude 
the possibility that the observed decrease in impedance is due to an effect 
of the solvent (methyl ethyl ketone) on the skin. The control sites were 
exposed neither to the methacrylate under investigation, nor to the solvent 
during the experiments. 
Another investigation, in which one of the two control sites is indeed 
exposed to the solvent, will be necessary for a further support of the con-
clusion. It is not sufficient to state that a 20 minute exposure to methyl 
ethyl ketone hardly affected the measured parameters in other volunteers. 
It cannot be excluded that the volunteers, exposed to the methacrylates in 
the experiments reported in this chapter, might, however, have a lowered 
natural resistance against this solvent. 
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S U M M A R Y 
The greatly expanded number of applications of acrylic monomers has led 
to a considerable exposure of the human skin to these compounds. 
This may lead to irritant or allergic reactions of the skin, or to 
systemic effects, when the acrylic monomer penetrates through the skin. 
Special attention is given to the use of acrylic monomers in adhesive 
materials, since this application is likely to result in intimate contact 
with the skin. 
In Chapter 1 four subject-matters are described: 
1. the basic principles of polymerization reactions, leading to the 
production of plastic materials; 
2. the applications of acrylic monomers in the manufacturing of a great 
variety of polymers; 
3. the basic principles of adhesive bonding; 
4. a review of the toxicological literature on acrylate esters. 
Chapter 2 deals with the assessment of the mutagenic activity of 27 acrylate 
esters and 5 acrylamides. To this purpose the Salmonella microsome assay was 
selected as the test method, in view of its high sensitivity and extensive 
validation. 
No mutagenic effects are observed with this method. The addition of an 
external metabolizing system (liver homogenate) had no influence on this 
result. The conclusion is that this result diminishes the probability of a 
carcinogenic effect of the tested acrylic monomers. 
In Chapter 3 acrylic constituents of adhesive tapes are investigated for 
their sensitizing potential with guinea pig test methods. 
2-Ethylhexyl acrylate proved to be a strong sensitizer in the Freund's 
Complete Adjuvant Test. However, an extract from an adhesive tape, con­
taining 2-ethylhexyl acrylate, did not provoke any allergic reactions in the 
guinea pigs, sensitized to 2-ethylhexyl acrylate. 
Acrylamide, N-hydroxymethyl acrylamide and Ν,Ν'-methylene bis acrylamide 
appeared to be moderate sensitizers in the Split Adjuvant Test, while meth­
acrylamide, t-butyl acrylamide, N-dodecyl maleamic acid and N-t-butyl maleamic 
acid appeared to be weak or non-sensitizers with the Split Adjuvant Test. 
Acrylamide, methacrylamide and N-hydroxymethyl acrylamide were also investigat­
ed with the Freund's Complete Adjuvant Test. A good correlation between the 
two test methods is found. 
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When it is allowed to use the data, obtained in guinea pig experiments, 
for the human situation, then the difference in sensitizing potential of the 
above mentioned substances may be used as a guideline in allergen replacement. 
A strongly sensitizing impurity in acrylic acid is identified as ci,ß-di-
acryloxy propionic acid with the aid of physico-chemical analysis and the 
Freund's Complete Adjuvant Test. This finding demonstrates the necessity of 
using pure products as starting materials in the synthesis of adhesives and 
other end products. 
The rapid diffusion of methyl methacrylate through surgeons' gloves is 
described in Chapter 4. Furthermore, methyl methacrylate is able to act as 
a solvent for auxiliary substances in the rubber glove. Both properties of 
methyl methacrylate mean a risk of sensitization for the personnel in the 
operating theatre. These people come into contact with the methyl meth-
acrylate, present in bone cement used to fix endoprostheses to bone. 
Preliminary studies indicate that butyl acrylate and acrylamide are also 
able to penetrate through surgeons' gloves. 
Chapter 5 deals with the permeation in vivo of methyl methacrylate and 
methyl acrylate through the guinea pig skin. The comparison of the excretion 
of radioactive labelled metabolites of the 2 acrylate esters after intra-
venous or epicutaneous dosage, leads to an estimation of the permeation in 
vivo with the aid of the mathematical process called deconvolution. 
Methyl acrylate penetrates faster through the guinea pig skin than methyl 
methacrylate. Methyl acrylate appears to bind irreversibly to the erythrocytes; 
this in contrast with acrylic acid or methyl methacrylate. The latter result 
demonstrates the importance of hydrolysis in the detoxification of acrylate 
esters, and of the importance of the methyl group at the α-carbon atom for 
diminishing the toxicity of acrylate esters. 
Biotransformation of both acrylate esters in the skin could be demonstrated, 
but this local biotransformation made an exact determination of the permeation 
rate with the method used impossible. 
In Chapter 6 the measurement of the irritant potential of 5 monometh-
acrylate esters on the living human skin is described. As parameters for 
damage to the skin deviations of water vapour loss and impedance of the skin, 
as compared to control sites on the skin, are taken. An exposure of the 
volunteers of 20 minutes or longer to a solution of one of the methacrylate 
esters (2 M, 3 M, 4.5 M) in methyl ethyl ketone caused a decrease m impedance 
of 50% or more directly after exposure. 
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This result is suggestive for a health risk of the skin, exposed to 
comparable concentrations during a comparable time. However, an effect of 
the solvent on the skin was not excluded with certainty. 
Further experiments will be necessary to clarify this. 
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S A M E N V A T T I N G 
Het aantal toepassingen van acrylverbindingen is sinds de 2e wereldoorlog 
sterk toegenomen. Terwijl vroeger vooral de nadruk lag op buik-productie in 
gesloten systemen (т.п. perspex productie), zijn er geleidelijk aan ook meer 
ambachtelijke toepassingen gevonden voor het gebruik van deze stoffen. Tand­
prothesemateriaal, drukinkten, verven en lijmen bevatten vaak acrylverbindingen. 
Deze nieuwe toepassingen gaan gepaard met een ander risico en een gewijzigd 
patroon van blootstelling. Derhalve hoort naast de aandacht voor de gevolgen 
van acute kortdurende blootstelling aan hoge concentraties, zoals die voor­
komen na een ongeluk in een gesloten productiesysteem, nu ook de invloed van 
frequentere, langdurige blootstelling aan lage concentraties onderzocht te 
worden. Met name de blootstelling van de huid kan hierbij aanzienlijk zijn. 
Hierbij kan de huid doelwit-orgaan zijn, met als gevolg b.v. een dermatitis 
op allergische of orthoergische basis. Daarnaast kan een stof door de huid 
heen penetreren en een heel scala aan systemische effecten veroorzaken. 
Teneinde een bijdrage te leveren tot een zo verantwoord mogelijke nsico-
evaluatie van het gebruik van acrylverbindingen, staan m dit proefschrift 
een aantal experimentele onderzoeken beschreven naar het dermatotoxicologisch 
gedrag van acrylverbindingen. Met name werd aandacht besteed aan het gebruik 
van acrylverbindingen in lijmen, aangezien hierbij intensief contact met de 
huid regelmatig voorkomt. 
In hoofdstuk 1 worden in een algemene inleiding de volgende onderwerpen 
uiteengezet: 
1. De basisprincipes van de productie van kunststoffen door polymensatie-
reacties. 
2. De toepassingen van de diverse acrylverbindingen. 
3. De fysich-chemische achtergrond van de aard van lijmverbindingen. 
4. Een overzicht van de toxicologische literatuur over acrylesters. 
In het tweede hoofdstuk wordt een onderzoek beschreven naar de mutagene 
eigenschappen van 27 acrylesters en 5 acrylamides. Omdat uit eerdere onder­
zoeken naar voren was gekomen dat acrylverbindingen een covalente binding met 
eiwitten kunnen aangaan, werd besloten om na te gaan of deze monomeren ook 
een structurele verandering van DNA, een mutatie, kunnen bewerkstelligen. 
De Salmonella-microsoom test of Ames-test is hiervoor gebruikt, aangezien 
deze mutagemteitstest uitgebreid gevalideerd en zeer sensitief is. Als een 
stof mutageen is, dan is de kans dat deze stof carcinogeen is sterk verhoogd. 
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Met de gebruikte test-methode kon evenwel geen mutagene activiteit van de 
onderzochte verbindingen gedetecteerd worden. 
Het derde hoofdstuk behandelt de sensibiliserende eigenschappen van acry-
laten, welke voorkomen in zelfklevende pleisters. Twee dierexperimentele 
methoden werden gebruikt om de sensibiliserende potentie vast te leggen, nl. 
de Freund's Complete Adjuvant Test (FCAT) en de Split Adjuvant Test (SAT). 
2-Ethylhexylacrylaat bleek een sterke sensibilisator in de FCAT, maar een 
extract van een pleister, welke 2-ethylhexyl·acrylaat bevatte, gaf geen aller­
gische reactie in de voor 2-ethylhexylacrylaat gesensibiliseerde dieren. 
Blijkbaar was de concentratie van vrij 2-ethylhexylacrylaat in de pleister te 
laag om nog een allergische reactie te bewerkstelligen. 
Acrylamide, N-hydroxymethylacrylamide en Ν,Ν'-methyleenbisacrylamide ble­
ken matige sensibilisatoren te zijn in de SAT, terwijl methacrylamide, 
t-butylacrylamide, N-dodecylmaleamide zuur en N-t-butylmaleamide zuur zwak 
of niet sensibiliseerden in de SAT. Acrylamide, N-hydroxymethylacrylamide 
en methacrylamide werden ook met de FCAT onderzocht. De resultaten van beide 
onderzoeksmethoden bleken goed met elkaar overeen te stemmen. De keuze tussen 
beide testmethoden hangt af van de fysisch-chemische eigenschappen van de 
stof. Om de FCAT te kunnen gebruiken - deze is eenvoudiger uit te voeren -
dient de te onderzoeken stof oplosbaar te zijn in water of olie. 
Het waargenomen verschil in sensibiliserende potentie tussen de hierboven 
genoemde stoffen kan gebruikt worden als een richtlijn bij eventueel nood­
zakelijke vervanging. Zo zou het matig sensibiliserende acrylamide bij een 
hiervoor opgetreden sensibilisatie vervangen kunnen worden door methacryl­
amide . 
Dat men ook bij monomeren zonder allergene eigenschappen op zijn hoede 
hoort te zijn voor het risico van sensibilisatie, wordt geïllustreerd door 
het vinden van een sterk allergene verontreiniging in monsters van acryl-
zuur (hoofdstuk 3.4.). Deze verontreiniging kon geïdentificeerd worden als 
α, B-diacryloxypropionzuur. Deze stof ontstaat vermoedelijk als bijproduct 
van een bepaalde industriële synthese van acrylzuur. Indien dit verontrei-
nigde acrylzuur gebruikt wordt voor de fabricage van producten als lijmen 
en verven, waarbij huidcontact frequent voorkomt, dan betekent dat een duide-
lijk risico van sensibilisatie. Het gebruik van zo zuiver mogelijke grond-
stoffen bij dit soort productieprocessen lijkt dan ook noodzakelijk. 
Methylmethacrylaat is het voornaamste bestanddeel van "botcement", dat 
gebruikt wordt om metalen heup- en knieprotheses te bevestigen aan bot. 
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Een orthopeed komt aldus tijdens b.v. een heupprothese-operatie in contact 
met methylmethacrylaat, een bekende contact-sensibilisator. De mate van dif-
fusie van methylmethacrylaat door een aantal chirurgische handschoenen dient 
men te kennen, alvorens een advies te kunnen geven welke handschoen voor de 
orthopedische praktijk het meest geschikt is. Een onderzoek naar deze door-
laatbaarheid staat beschreven in hoofdstuk 4. Geen van de onderzochte 11 
merken handschoenen bleek in staat langer dan 5 minuten het methylmethacrylaat 
tegen te houden. Bovendien bleek dat de rubber-hulpstoffen uit de handschoenen 
wegdiffundeerden onder invloed van het methylmethacrylaat. Aangezien rubber-
hulpstoffen tot de meest frequente veroorzakers van contact-allergieën behoren, 
betekent dit nog een additief risico voor de geëxponeerde personen. Een oriën-
terend onderzoek toonde voorts aan dat butylacrylaat en acrylamide ook door 
deze rubber handschoenen heen penetreerden. 
Hoofdstuk 5 gaat over de doorlaatbaarheid in VÌVO van methylacrylaat en 
methylmethacrylaat door de huid van de cavia. De vergelijking van het verloop 
van de uitscheiding van radioactief gemerkte acrylaten tussen intraveneuze 
en epicutane toediening, geeft hierbij met behulp van het wiskundige proces 
van deconvolutie een schatting van de doorlaatbaarheid in vivo. Methylacry-
laat gaat sneller door de caviahuid dan methylmethacrylaat. Methylacrylaat 
gaat een irreversibele binding aan met de rode bloedcellen, dit in tegen-
stelling tot methylmethacrylaat of acrylzuur. Dit laatste resultaat toont het 
belang aan van de methylgroep aan het α-koolstofatoom voor de vermindering 
van de toxiciteit en het belang van de hydrolyse bij de ontgifting van de 
acrylesters. 
Biotransformatie van beide acrylesters m de huid kon aangetoond worden. 
Deze biotransformatie verhinderde wel een exactere bepaling van de doorlaat­
baarheid van de huid met deze methode. 
In hoofdstuk 6 wordt de meting van de irriterende eigenschappen van 5 
monomethacrylaten op de menselijke huid beschreven. Hierbij zijn als para­
meters voor beschadiging van de huid de waterdampafgifte en de electrische 
weerstand van de huid genomen, vergeleken met de waarden hiervan op controle­
plaatsen op de huid. Als de huid van de binnenzijde van de onderarm van vrij­
willigers blootgesteld werd gedurende 20 minuten of langer aan een oplossing 
van een van de methacrylaten in methylethylketon in concentraties van 2 M of 
hoger, dan werd een daling in de electrische weerstand van de huid gezien 
van 50% of meer vergeleken met de controlewaarden. Deze daling van de huid­
weerstand werd alleen gezien onmiddellijk na de blootstelling. Hoewel een 
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effect van het gebruikte oplosmiddel op de huid niet volledig uitgesloten 
kan worden, is het verkregen resultaat toch suggestief voor een gezondheids-
risico van de huid, die blootgesteld wordt aan dergelijke concentraties ge-
durende vergelijkbare tijden. 
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S T E L L I N G E N 
Het gebruik van handschoenen ter bescherming tegen contact met een be-
paalde stof dient voorafgegaan te worden door een onderzoek naar de door-
laatbaarheid Van deze handschoenen voor deze bepaalde stof. 
Het ongereglementeerd toestaan van de aanbeveling "hypo-allergeen" op 
een gebruiksartikel werkt kwakzalverij in de hand. 
Gezien de promotor-werking van benzoyl peroxide is de toepassing van deze 
stof in locale anti-acné preparaten niet aan te raden. 
Slaga, TJ, Klein-Szanto AJP, Triplett LL, Yotti LP, Trosko 
JE, Science 1982; 231: 1023-1025. 
Het postuleren van de afwezigheid van een no-effect level bi] genotoxische 
stoffen is celbiologisch gezien terecht, maar vanuit een epidemiologisch 
standpunt uit bekeken onjuist. 
Elke arbeidssituatie fungeert in wezen ten dele als een proeflaboratorium 
van de volksgezondheid en de milieuhygiëne. Daarom dienen zowel de arbei-
ders als de arbeidsomstandigheden adequaat begeleid en geobserveerd te 
worden vanuit de arbeidsgeneeskunde. 
Documentatie- en archivenngstechnieken horen thuis in het basisprogramma 
van een wetenschappelijke opleiding. 
Bij de bemesting van landbouwgrond dient zuiveringsslib, gezien de daarin 
voorkomende concentraties zware metalen, niet gebruikt te worden. 
De sinds Plato verkondigde hypothese, dat een excellent onderzoeker ook 
een excellent bestuurder zal zijn en vice versa, wordt niet bevestigd 
m de praktijk van de universiteitssituatie. 
Plato, Politela, 473d. 
De overheersende positie van de LD bij wettelijke veiligheidsvoorschrif-
ten toont aan dat de adsorptie van relevante toxicologische onderzoeks-
methoden aan de wetgever een uiterst traag proces is. 
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tegelijkertijd de vooruitgang van de wetenschap. 
New Scientist, 20/27 December 1984. 
Theo Waegemaekers 
6 juni 1985 


